1,841 results on '"Fernandez, N"'
Number of results to display per page
Search Results
202. Detection and quantification of antibody to SARS-CoV-2 receptor binding domain provides enhanced sensitivity, specificity and utility
- Author
-
Tedder, RS, Parker, E, Sureda-Vives, M, Fernandez, N, Randell, P, Marchesin, F, Katsanovskaja, K, Harvey, R, Lilley, A, Harris, BHL, Zuhair, M, Fertleman, M, Ijaz, S, Dicks, S, Short, C-E, Quinlan, R, Taylor, GP, McKay, P, Hu, K, Rosa, A, Roustan, C, Zuckerman, M, El Bouzidi, K, Cooke, G, Flower, B, Moshe, M, Elliott, P, Spencer, AJ, Lambe, T, Gilbert, SC, Kingston, H, Baillie, JK, Openshaw, P, Semple, M, Cherepanov, P, McLure, M, National Institute for Health Research, UKRI MRC COVID-19 Rapid Response Call, and UK Research and Innovation
- Abstract
Background: Accurate and sensitive detection of antibody to SARS-CoV-2 remains an essential component of the pandemic response. Measuring antibody that predicts neutralising activity and the vaccine response is an absolute requirement for laboratory-based confirmatory and reference activity. Methods: The viral receptor binding domain (RBD) constitutes the prime target antigen for neutralising antibody. A double antigen binding assay (DABA) provides the most sensitive format. It has been exploited in a novel hybrid manner employing an S1 solid-phase preferentially presenting RBD once solid-phase bound, coupled with a labelled RBD conjugate, used in a two-step sequential assay. Findings: This assay showed a specificity of 100% on 825 pre COVID-19 samples and a potential sensitivity of 99.6% on 276 recovery samples, predicting quantitatively the presence of neutralising antibody determined by pseudo-type neutralisation and by plaque reduction. Anti-RBD is also measurable in ferrets immunised with ChadOx1 nCoV-19 vaccine. The early response at presentation with illness, elevated responsiveness with disease severity, detection of asymptomatic seroconversion and persistence after the loss of antibody to the nucleoprotein (anti-NP) are all documented. Trial Registration: The ISARIC WHO CCP-UK study was registered at https://www.isrctn.com/ISRCTN66726260 and designated an Urgent Public Health Research Study by NIHR. Interpretation: The hybrid DABA displays the attributes necessary for an antibody test to be used in both clinical and reference serology. It allows the neutralising antibody response to be inferred early in infection and potentially in vaccine recipients. It is also of sufficient sensitivity to be used to provide serological confirmation of prior infection and provides a more secure measure for seroprevalence studies in the population generally than does anti-NP based on the Architect platform. Funding: This work is variously supported by grants from: the National Institute for Health Research (NIHR; award CO-CIN-01), the Medical Research Council (MRC; grant MC_PC_19059 and MC_PC_19078), MRC NIHR (grant CV220-111) and by the NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections at University of Liverpool in partnership with Public Health England (PHE), in collaboration with Liverpool School of Tropical Medicine and the University of Oxford (award 200907), NIHR HPRU in Respiratory Infections at Imperial College London with PHE (award 200927), Wellcome Trust and Department for International Development (DID; 215091/Z/18/Z), the Bill and Melinda Gates Foundation (OPP1209135), Liverpool Experimental Cancer Medicine Centre (grant reference C18616/A25153), NIHR Biomedical Research Centre at Imperial College London (IS-BRC-1215-20013), EU Platform for European Preparedness Against (Re-)emerging Epidemics (PREPARE; FP7 project 602525), and NIHR Clinical Research Network for providing infrastructure support for this research. Declaration of Interests: RST, MOM and PC report patent pending (Patent Application No. 2011047.4 for “SARS-CoV-2 antibody detection assay). All other authors declare no competing interests. Ethics Approval Statement: The use of tissues was approved by the CDRTB Steering Committee in accordance with the responsibility delegated by the National Research Ethics Service (South Central Ethics Committee – C, NRES reference 15/SC/0089).
- Published
- 2021
203. Perspectives on the role of magnetic resonance imaging (Mri) for noninvasive evaluation of diabetic kidney disease
- Author
-
Mora-Gutiérrez, J.M. (José María), Fernández-Seara, M.A. (María A.), Echeverría-Chasco, R. (Rebeca), and Garcia-Fernandez, N. (Nuria)
- Subjects
Perfusion ,Kidney function ,Magnetic resonance imaging ,Oxygenation ,Arterial spin labeling ,Chronic kidney disease ,Diffusion weighted imaging ,Blood oxygen-dependent level ,Diabetic kidney disease ,Fibrosis - Abstract
Renal magnetic resonance imaging (MRI) techniques are currently in vogue, as they provide in vivo information on renal volume, function, metabolism, perfusion, oxygenation, and microstructural alterations, without the need for exogenous contrast media. New imaging biomarkers can be identified using these tools, which represent a major advance in the understanding and study of the different pathologies affecting the kidney. Diabetic kidney disease (DKD) is one of the most important diseases worldwide due to its high prevalence and impact on public health. However, its multifactorial etiology poses a challenge for both basic and clinical research. Therefore, the use of novel renal MRI techniques is an attractive step forward in the comprehension of DKD, both in its pathogenesis and in its detection and surveillance in the clinical practice. This review article outlines the most promising MRI techniques in the study of DKD, with the purpose of stimulating their clinical translation as possible tools for the diagnosis, follow-up, and monitoring of the clinical impacts of new DKD treatments.
- Published
- 2021
204. Intraoperative Scintigraphy With Portable Gamma Camera for the Localization of Interaortocaval Paraganglioma
- Author
-
Perez-Santiago L, Cassinello-Fernandez N, Alfonso-Ballester R, Diaz-Exposito R, Moscardo-Navarro A, and Ortega-Serrano J
- Abstract
A 15-year-old adolescent girl diagnosed of interaortocaval paraganglioma with a positive 123I-MIGB SPECT/CT and 1 unsuccessful prior surgery was operated on with the assistance of a handheld gamma camera. Once the lesion was located and removed, 2 images were taken, one of the surgical field (without 123I-MIGB uptake) and another of the tumor ex vivo (with high 123I-MIGB uptake), confirming that the lesion had been satisfactorily excised. This case highlights the use of a portable gamma camera as a useful tool to locate this rare tumor, with a SPECT/CT positive for 123I-MIGB and a difficult anatomical location suspected. Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
- Published
- 2021
205. Levels of Predominant Intestinal Microorganisms in 1 Month-Old Full-Term Babies and Weight Gain during the First Year of Life
- Author
-
Gonzalez S, Selma-Royo M, Arboleya S, Martinez-Costa C, Solis G, Suarez M, Fernandez N, de los Reyes-Gavilan C, Diaz-Coto S, Martinez-Camblor P, Collado M, and Gueimonde M
- Subjects
infants ,Staphylococcus ,microbiota ,weight gain ,Bifidobacterium ,Enterococcus - Abstract
The early life gut microbiota has been reported to be involved in neonatal weight gain and later infant growth. Therefore, this early microbiota may constitute a target for the promotion of healthy neonatal growth and development with potential consequences for later life. Unfortunately, we are still far from understanding the association between neonatal microbiota and weight gain and growth. In this context, we evaluated the relationship between early microbiota and weight in a cohort of full-term infants. The absolute levels of specific fecal microorganisms were determined in 88 vaginally delivered and 36 C-section-delivered full-term newborns at 1 month of age and their growth up to 12 months of age. We observed statistically significant associations between the levels of some early life gut microbes and infant weight gain during the first year of life. Classifying the infants into tertiles according to their Staphylococcus levels at 1 month of age allowed us to observe a significantly lower weight at 12 months of life in the C-section-delivered infants from the highest tertile. Univariate and multivariate models pointed out associations between the levels of some fecal microorganisms at 1 month of age and weight gain at 6 and 12 months. Interestingly, these associations were different in vaginally and C-section-delivered babies. A significant direct association between Staphylococcus and weight gain at 1 month of life was observed in vaginally delivered babies, whereas in C-section-delivered infants, lower Bacteroides levels at 1 month were associated with higher later weight gain (at 6 and 12 months). Our results indicate an association between the gut microbiota and weight gain in early life and highlight potential microbial predictors for later weight gain.
- Published
- 2021
206. Community Transmission and Viral Load Kinetics of SARS-CoV-2 Delta (B.1.617.2)Variant in Vaccinated and Unvaccinated Individuals
- Author
-
Jake Dunning, Samuel Bremang, R. Varro, Vetkar A, Dustan S, Derqui-Fernandez N, Graham P. Taylor, J. Fenn, R. Kundu, Quinn, Hammett S, Ajit Lalvani, Joanna Ellis, J. S. Narean, Koycheva A, David C. Jackson, Timesh D Pillay, Miah S, Anjna Badhan, Emily Conibear, Andre Charlett, Hakki S, Wendy S. Barclay, Madon Kj, Hamish Houston, Samuel J, Anderson C, Paul S. Freemont, C. Tejpal, Angie Lackenby, Maria Zambon, Cutajar J, Jake Barnett, Michael A. Crone, Whitfield Mg, McDermott E, Luca C, Neil M. Ferguson, Shazaad Ahmad, and Aran Singanayagam
- Subjects
Delta ,History ,Polymers and Plastics ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Breakthrough infection ,Virology ,Industrial and Manufacturing Engineering ,law.invention ,Vaccination ,Transmission (mechanics) ,law ,Medicine ,Transmission risks and rates ,Business and International Management ,business ,Viral load ,Cohort study - Abstract
Background: The SARS-CoV-2 Delta variant is highly transmissible and spreading globally but a detailed understanding of community transmission risks in highly vaccinated populations is lacking. Methods: Between September 2020 and August 2021, we recruited 510 community contacts of 422 UK COVID-19 cases to a cohort study. A total of 7194 upper respiratory tract (URT) samples were tested from sequential daily sampling of participants for up to 20 days. We analysed transmission risk by vaccination status for 139 contacts exposed to the Delta variant. We compared viral load (VL) trajectories from fully-vaccinated cases of Delta infection (n=19) with unvaccinated Delta (n=10), Alpha (n=39) and pre-Alpha (n=49) infections. Findings: The household secondary attack rate for fully-vaccinated contacts exposed to Delta was 19.7% (95%CI:11.6-31.3%), compared with 35.7% (95%CI:16.4-61.2%) in the unvaccinated. One third of infections in Delta-exposed contacts arose from fully-vaccinated index cases and one half of infected contacts were also fully-vaccinated. Seven transmission events between fully vaccinated index-contact pairs occurred. Genomic analysis confirmed transmission pathways between fully-vaccinated individuals within three households. Peak VL was similar in vaccinated and unvaccinated individuals with Delta variant infection but vaccinated Delta cases saw significantly faster VL decline than unvaccinated Alpha or Delta cases. Within infected individuals, faster VL growth was correlated with higher peak VL and slower decline. Interpretation: Although vaccination reduces the risk of Delta infection and causes some changes to viral kinetics, fully-vaccinated individuals with breakthrough infections have peak URT VL similar to unvaccinated cases and can efficiently transmit infection in household settings, including to fully vaccinated contacts. Funding: National Institute for Health Research (Award:NIHR200927) Declaration of Interest: The authors declare no relevant conflicts. Ethical Approval: The study was approved by the Health Research Authority (Research Ethics Committee reference: 20/NW/0231).
- Published
- 2021
207. Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension
- Author
-
Mantegazza, R, Wolfe, GI, Muppidi, S, Wiendl, H, Fujita, KP, O'Brien, FL, Booth, HDE, Howard, JF, Illa I., Cortés-Vicente E., Díaz-Manera J., Querol L.A., Rojas-García R., Vidal-Fernandez N., and REGAIN Study Group
- Abstract
Objective To evaluate whether eculizumab helps patients with anti-acetylcholine receptor-positive (AChR+) refractory generalized myasthenia gravis (gMG) achieve the Myasthenia Gravis Foundation of America (MGFA) post-intervention status of minimal manifestations (MM), we assessed patients' status throughout REGAIN (Safety and Efficacy of Eculizumab in AChR+ Refractory Generalized Myasthenia Gravis) and its open-label extension. Methods Patients who completed the REGAIN randomized controlled trial and continued into the open-label extension were included in this tertiary endpoint analysis. Patients were assessed for the MGFA post-intervention status of improved, unchanged, worse, MM, and pharmacologic remission at defined time points during REGAIN and through week 130 of the open-label study. Results A total of 117 patients completed REGAIN and continued into the open-label study (eculizumab/eculizumab: 56; placebo/eculizumab: 61). At week 26 of REGAIN, more eculizumab-treated patients than placebo-treated patients achieved a status of improved (60.7% vs 41.7%) or MM (25.0% vs 13.3%; common OR: 2.3; 95% CI: 1.1-4.5). After 130 weeks of eculizumab treatment, 88.0% of patients achieved improved status and 57.3% of patients achieved MM status. The safety profile of eculizumab was consistent with its known profile and no new safety signals were detected. Conclusion Eculizumab led to rapid and sustained achievement of MM in patients with AChR+ refractory gMG. These findings support the use of eculizumab in this previously difficult-to-treat patient population.
- Published
- 2021
208. Exploring allele specific methylation in drug dependence susceptibility
- Author
-
Pineda L, Cabana J, Grau-López L, Daigre C, Sánchez-Mora C, Palma-Álvarez RF, Ramos-Quiroga JA, Ribasés M, Cormand B, and Fernandez N
- Subjects
ECHDC2 ,SNP ,SCP2 ,Brain DNA methylation ,Association ,CTNNBL1 - Abstract
Drug dependence is a neuropsychiatric condition that involves genetic, epigenetic and environmental factors. Allele-specific methylation (ASM) is a common and stable epigenetic mechanism that involves genetic variants correlating with differential levels of methylation at CpG sites. We selected 182 single-nucleotide polymorphisms (SNPs) described to influence cis ASM in human brain regions to evaluate their possible contribution to drug dependence susceptibility. We performed a case-control association study in a discovery sample of 578 drug-dependent patients (including 428 cocaine-dependent subjects) and 656 controls from Spain, and then, we followed-up the significant associations in an independent sample of 1119 cases (including 589 cocaine-dependent subjects) and 1092 controls. In the discovery sample, we identified five nominal associations, one of them replicated in the follow-up sample (rs6020251). The pooled analysis revealed an association between drug dependence and rs6020251 but also rs11585570, both overcoming the Bonferroni correction for multiple testing. We performed the same analysis considering only cocaine-dependent patients and obtained similar results. The rs6020251 variant correlates with differential methylation levels of cg17974185 and lies in the first intron of the CTNNBL1 gene, in a genomic region with multiple histone marks related to enhancer and promoter regions in brain. Rs11585570 is an eQTL in brain and blood for the SCP2 and ECHDC2 genes and correlates with differential methylation of cg27535305 and cg13461509, located in the promoter regions of both genes. To conclude, using an approach that combines genetic and epigenetic data, we highlighted the CTNNBL1, SCP2 and ECHDC2 genes as potential contributors to drug dependence susceptibility.
- Published
- 2021
209. Towards an Automatic Generation of Persuasive Messages
- Author
-
Lipa-Urbina, E., Condori-Fernandez, N., Suni-Lopez, F., Ali, Raian, Lugrin, Birgit, Charles, Fred, Ali, Raian, Lugrin, Birgit, Charles, Fred, Software and Sustainability (S2), Network Institute, and Software & Services
- Subjects
business.industry ,Computer science ,Text generation ,Novelty ,Natural language generation ,Training phase ,Artificial intelligence ,business ,computer.software_genre ,computer ,Natural language processing ,Diversity (business) - Abstract
In the last decades, the Natural Language Generation (NLG) methods have been improved to generate text automatically. However, based on the literature review, there are not works on generating text for persuading people. In this paper, we propose to use the SentiGAN framework to generate messages that are classified into levels of persuasiveness. And, we run an experiment using the Microtext dataset for the training phase. Our preliminary results show 0.78 of novelty on average, and 0.57 of diversity in the generated messages.
- Published
- 2021
210. Effects of BNT162b2 mRNA Vaccination on COVID-19 Disease, Hospitalisation and Mortality in Nursing Homes and Healthcare Workers: A Prospective Cohort Study Including 28,594 Nursing Home Residents, 26,238 Nursing Home Staff, and 61,951 Healthcare Workers in Catalonia
- Author
-
Juan Carlos Contel, Martinez-Marcos M, Eduardo Hermosilla, Josep M. Argimon, Mireia Fàbregas, Yolanda Lejardi, Fina-Aviles F, Enfedaque B, Ermengol Coma, Xintong Li, Jover A, Daniel Prieto-Alhambra, Mora-Fernandez N, M Medina-Peralta, and Carmen Cabezas
- Subjects
medicine.medical_specialty ,business.industry ,Proportional hazards model ,Medical record ,Hazard ratio ,medicine.disease ,Comorbidity ,Vaccination ,Clinical research ethics ,Family medicine ,Health care ,Medicine ,business ,Prospective cohort study - Abstract
Background: Spain began vaccinating priority groups against COVID-19 with BNT162b2 in late December 2020. We report associations of vaccination with COVID-19 infection, hospitalisation, and mortality among nursing home residents, nursing home staff, and healthcare workers. Methods: We analysed three cohorts of all nursing home residents, nursing home staff, and healthcare workers in Catalonia on 27 December 2020. Data were obtained from linked primary care, RT-PCR and lateral flow test, hospital, and mortality records. Those with a pre-study COVID-19 diagnosis or no linked electronic medical records were excluded. Two doses of BNT162b2 were administered 3 weeks apart. Participants were followed until the earliest of an outcome (confirmed COVID-19 infection, hospitalisation, and mortality) or 5 March 2021. Participants could contribute data to the unvaccinated, one-dose, and two-dose groups. Analyses were conducted using time-varying Cox regression. Multivariable adjustment for imbalances in socio-demographics, comorbidity, and polypharmacy. Findings: We included 28,594 nursing home residents, 26,238 nursing home staff, and 61,951 healthcare workers, of whom 2,405, 1,584, and 2,672 received COVID-19 diagnoses; 383, 35, and 76 were hospitalised; and 409, 0, and 1 died. The adjusted hazard ratio (HR) (95% confidence interval) for COVID-19 infection after two-dose vaccination was 0·08 (0·07-0·09) for nursing home residents, 0·12 (0·10-0·15) for nursing home staff, and 0·05 (0·04-0·07) for healthcare workers. The adjusted HRs for hospitalisation and mortality after two-dose vaccination were 0·03 (0·02-0·05) and 0·02 (0·01-0·03), respectively, for nursing home residents. Nursing home staff and healthcare workers recorded insufficient events for mortality analysis. Interpretation Vaccination was associated with 85%-96% reduction in SARS-CoV-2 infection in all three cohorts, and bigger reductions in hospitalisations and mortality amongst nursing home residents for up to two months. More data are needed on the long-term effects of COVID-19 vaccines. Funding: Partially supported by National Institute of Health Research UK, We do not have any other funding acknowledgements. Declaration of Interest: None to declare. Ethical Approval: The study was approved by the Clinical Research Ethics Committee of the IDIAP Jordi Gol with reference number 21/045-PCV.
- Published
- 2021
211. Reaching Deeper: Absolute In Vivo Thermal Reading of Liver by Combining Superbright Ag2S Nanothermometers and In Silico Simulations
- Author
-
Lifante J., Shen Y., Zabala Gutierrez I., Rubia-Rodríguez I., Ortega D., Fernandez N., Melle S., Granado M., Rubio-Retama J., Jaque D., Ximendes E. and This work was supported by the Spanish Ministry of Economy and Competitiveness under projects MAT2016‐75362‐C3‐1‐R, MAT2017‐83111R, and MAT2017‐85617‐R, by the Instituto de Salud Carlos III (PI16/00812), by the Comunidad Autónoma de Madrid (B2017/BMD‐3867 RENIM‐CM), and cofinanced by the European Structural and investment fund. Additional funding was provided by the European Union's Horizon 2020 FET Open programme (Grant Agreement No. 801305, NanoTBTech), the Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal project IMP18_38 (2018/0265), and also by COST action CA17140. Y.S. acknowledges a scholarship from the China Scholarship Council (No. 201806870023). I.Z.G. thanks UCM‐Santander for a predoctoral contract (CT63/19‐CT64/19). D.O. and I.R. acknowledge financial support from the Community of Madrid under Contract No. PEJD‐2017‐PRE/IND‐3663, and from the Spanish Ministry of Science and Innovation through the Ramón y Cajal grant RYC2018‐025253‐I, Research Networks grant RED2018‐102626‐T and the PID2019‐106211RB‐I00 grant as well as the Ministry of Economy and Competitiveness through the grants MAT2017‐85617‐R, MAT2017‐88148R and the 'Severo Ochoa' Program for Centers of Excellence in R&D (SEV‐2016‐0686). D.O. and I.R. also acknowledge support from the 'NoCanTher' project, which has received funding from the European Union's Horizon 2020 research and innovation programme under Grant Agreement No. 685795. E.X. is grateful for a Juan de la Cierva Formación scholarship (FJC2018‐036734‐I).
- Published
- 2021
212. Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study
- Author
-
Siddiqi, ZA, Nowak, RJ, Mozaffar, T, O'Brien, F, Yountz, M, Patti, F, Illa I., Cortés-Vicente E., Díaz-Manera J., Querol L.A., Rojas-García R., Vidal-Fernandez N., and Nye, Joan L.
- Subjects
myasthenia gravis ,refractory ,acetylcholine receptor ,rituximab ,eculizumab - Abstract
Introduction/Aims Individuals with refractory generalized myasthenia gravis (gMG) who have a history of rituximab use and experience persistent symptoms represent a population with unmet treatment needs. The aim of this analysis was to evaluate the efficacy and safety of eculizumab in patients with refractory anti-acetylcholine receptor antibody-positive (AChR(+)) gMG previously treated with rituximab. Methods This post hoc subgroup analysis of the phase 3 REGAIN study (NCT01997229) and its open-label extension (OLE; NCT02301624) compared baseline characteristics, safety, and response to eculizumab in participants who had previously received rituximab with those who had not. Rituximab use was not permitted within the 6 months before screening or during REGAIN/OLE. Results Of 125 REGAIN participants, 14 had received rituximab previously (7 received placebo and 7 received eculizumab). In the previous-rituximab group, 57% had used at least four other immunosuppressants compared with 16% in the no-previous-rituximab group. Myasthenia Gravis Activities of Daily Living total scores from eculizumab baseline to week 130 of eculizumab treatment improved in both the previous-rituximab and no-previous-rituximab groups (least-squares mean -4.4, standard error of the mean [SEM] 1.0 [n = 9] and least-squares mean -4.6, SEM 0.3 [n = 67], respectively; difference = 0.2, 95% confidence interval -1.88 to 2.22). In addition, in both groups, most patients who were treated with eculizumab for 130 weeks achieved a Myasthenia Gravis Foundation of America post-intervention status of minimal manifestations (66.7% and 65.0%, respectively). The eculizumab safety profile was similar between groups and consistent with its established profile. Discussion Eculizumab is an effective therapy for patients with refractory AChR(+) gMG, irrespective of whether they had received rituximab treatment previously.
- Published
- 2021
213. Reduced cue-induced reinstatement of cocaine-seeking behavior in Plcb1 +/- mice
- Author
-
Cabana J, Martín-García E, Gallego-Roman A, Maldonado R, Fernandez N, and Cormand B
- Abstract
Cocaine addiction causes serious health problems, and no effective treatment is available yet. We previously identified a genetic risk variant for cocaine addiction in the PLCB1 gene and found this gene upregulated in postmortem brains of cocaine abusers and in human dopaminergic neuron-like cells after an acute cocaine exposure. Here, we functionally tested the contribution of the PLCB1 gene to cocaine addictive properties using Plcb1+/- mice. First, we performed a general phenotypic characterization and found that Plcb1+/- mice showed normal behavior, although they had increased anxiety and impaired short-term memory. Subsequently, mice were trained for operant conditioning, self-administered cocaine for 10 days, and were tested for cocaine motivation. After extinction, we found a reduction in the cue-induced reinstatement of cocaine-seeking behavior in Plcb1+/- mice. After reinstatement, we identified transcriptomic alterations in the medial prefrontal cortex of Plcb1+/- mice, mostly related to pathways relevant to addiction like the dopaminergic synapse and long-term potentiation. To conclude, we found that heterozygous deletion of the Plcb1 gene decreases cue-induced reinstatement of cocaine-seeking, pointing at PLCB1 as a possible therapeutic target for preventing relapse and treating cocaine addiction.
- Published
- 2021
214. Effectiveness and efficiency of a special program to reduce the bariatric surgery waiting list at a tertiary hospital
- Author
-
Kraus-Fischer G, Alfonso-Ballester R, Mora-Oliver I, Cassinello-Fernandez N, and Ortega-Serrano J
- Abstract
INTRODUCTION: Bariatric surgery is one of the most common surgical practices in Spain. However, this procedure currently has longest delay on surgical waiting lists (SWL). We have developed a special surgical program that aims to reduce this waiting list and to assess the economic and clinical repercussions in a high-volume bariatric surgery unit. METHODS: A three-month prospective study was carried out comparing outcomes, results and perioperative resources consumed for 45 patients who underwent bariatric surgery. The patients were divided into 2 groups: patients who underwent the standard procedure in the operating room, and patients treated in the special program. Epidemiological, healthcare and economic factors were taken into account. RESULTS: Two homogeneous groups of patients were operated on, successfully reducing the SWL. Morbidity was similar in both groups and the average cost of the surgeries performed was 5,331.40; in the standard group, the cost was 5,372.50±798.10, and the cost of the special program group was 5,290.30±685.10, with no significant differences. CONCLUSIONS: In hospitals with a high volume of bariatric surgery, it is feasible to incorporate special surgical programs that are able to reduce surgical waiting lists, while maintaining quality criteria and without incurring a greater expense to the healthcare system.
- Published
- 2021
215. An Evaluation of Physiological Public Datasets for Emotion Recognition Systems
- Author
-
Mendoza, A., Cuno, A., Condori-Fernandez, N., Lovón, W.R., Lossio-Ventura, Juan Antonio, Valverde-Rebaza, Jorge Carlos, Díaz, Eduardo, Alatrista-Salas, Hugo, Software and Sustainability (S2), Network Institute, Software & Services, Lossio-Ventura, Juan Antonio, Valverde-Rebaza, Jorge Carlos, Díaz, Eduardo, and Alatrista-Salas, Hugo
- Subjects
Computer science ,business.industry ,05 social sciences ,Machine learning ,computer.software_genre ,050105 experimental psychology ,03 medical and health sciences ,ComputingMethodologies_PATTERNRECOGNITION ,0302 clinical medicine ,0501 psychology and cognitive sciences ,Emotion recognition ,Artificial intelligence ,Set (psychology) ,Baseline (configuration management) ,business ,computer ,030217 neurology & neurosurgery ,Reference dataset - Abstract
[Background] The performance of emotion recognition systems depends heavily on datasets used in their training, validation, or testing stages.[Aims] This research aims to evaluate the extent to which public available physiological datasets created for emotion recognition systems meet a set of reference requirements.[Method] Firstly, we analyze the applicability of some reference requirements proposed for stress datasets and adjust the corresponding evaluation criteria. Secondly, nine public physiological datasets were identified from a previous survey.[Results] None of the evaluated datasets satisfy all the reference requirements in order to be considered as a reference dataset for being used in the construction of reliable emotion recognition systems.[Conclusion] Although the evaluated datasets do not support the whole reference requirements, they provide a baseline for further development. Also, a greater effort is needed to establish specific reference requirements that can appropriately guide the creation of physiological datasets for emotion recognition systems.
- Published
- 2021
216. How Can Personality Influence Perception on Security of Context-Aware Applications?
- Author
-
Condori-Fernandez, N., Suni-Lopez, F., Muñante, D., Daneva, M., Condori-Fernandez, N., Suni-Lopez, F., Muñante, D., and Daneva, M.
- Abstract
Our lives are being transformed by context-aware software applications with important social, environmental, and economic implications. [Question/Problem] Experts recognized that quality attributes, e.g. security, are the cornerstone to get healthy social implications of these applications. However, do end-users (service consumers) perceive these attributes as so important? [Methodology] To answer this question, we designed a survey, to understand how end-users perceive security of context-aware software applications and how the users’ personality traits might influence their perceptions. To this end, we did a web-based survey that embeds two animated-demonstration videos in order to present i) the functionality of a context-aware mobile app, and ii) some vulnerabilities of the mobile app. It involved 48 subjects divided in two groups: subjects with software engineering (SE) background (Group A) and subjects without any SE background (Group B). [Results] Our study found that the importance of confidentiality and integrity is more clearly perceived by subjects with SE backgrounds (Group A). Accountability is more difficult to be perceived by subjects. And this difficulty can be even more pronounced for subjects without any SE background (Group B). Our findings suggest that importance preferences on security are influenced by personality types. For instance, open-minded people have a higher propensity to perceive the importance of confidentiality and integrity. Whilst, people with a high level of agreeableness hold quite different perceptions regarding the importance of authenticity and accountability. Analyzing the level of association between personality and the perceived importance on security, we found that the importance perceptions on confidentiality are influenced by the personality of subjects from Group B. And, the changes (positive an negative) in the importance perception on confidentiality are very strongly influenced by personality, even more so by the pe
- Published
- 2021
- Full Text
- View/download PDF
217. Fusarium : more than a node or a foot-shaped basal cell
- Author
-
Crous, P. W., Lombard, L., Sandoval-Denis, M., Seifert, K. A., Schroers, H-J, Chaverri, P., Gene, J., Guarro, J., Hirooka, Y., Bensch, K., Kema, G. H. J., Lamprecht, S. C., Cai, L., Rossman, A. Y., Stadler, M., Summerbell, R. C., Taylor, J. W., Ploch, S., Visagie, C. M., Yilmaz, N., Frisvad, J. C., Abdel-Azeem, A. M., Abdollahzadeh, J., Abdolrasouli, A., Akulov, A., Alberts, J. F., Araujo, J. P. M., Ariyawansa, H. A., Bakhshi, M., Bendiksby, M., Amor, A. Ben Hadj, Bezerra, J. D. P., Boekhout, T., Camara, M. P. S., Carbia, M., Cardinali, G., Castaneda-Ruiz, R. F., Celis, A., Chaturvedi, V, Collemare, J., Croll, D., Damm, U., Decock, C. A., de Vries, R. P., Ezekiel, C. N., Fan, X. L., Fernandez, N. B., Gaya, E., Gonzalez, C. D., Gramaje, D., Groenewald, J. Z., Grube, M., Guevara-Suarez, M., Gupta, V. K., Guarnaccia, V, Haddaji, A., Hagen, F., Haelewaters, D., Hansen, K., Hashimoto, A., Hernandez-Restrepo, M., Houbraken, J., Hubka, V, Hyde, K. D., Iturriaga, T., Jeewon, R., Johnston, P. R., Jurjevic, Z., Karalti, I, Korsten, L., Kuramae, E. E., Kusan, I, Labuda, R., Lawrence, D. P., Lee, H. B., Lechat, C., Li, H. Y., Litovka, Y. A., Maharachchikumbura, S. S. N., Marin-Felix, Y., Kemkuignou, B. Matio, Matocec, N., McTaggart, A. R., Mlcoch, P., Mugnai, L., Nakashima, C., Nilsson, R. H., Noumeur, S. R., Pavlov, I. N., Peralta, M. P., Phillips, A. J. L., Pitt, J. , I, Polizzi, G., Quaedvlieg, W., Rajeshkumar, K. C., Restrepo, S., Rhaiem, A., Robert, J., Robert, V, Rodrigues, A. M., Salgado-Salazar, C., Samson, R. A., Santos, A. C. S., Shivas, R. G., Souza-Motta, C. M., Sun, G. Y., Swart, W. J., Szoke, S., Tan, Y. P., Taylor, J. E., Taylor, P. W. J., Tiago, P. , V, Vaczy, K. Z., van de Wiele, N., van der Merwe, N. A., Verkley, G. J. M., Vieira, W. A. S., Vizzini, A., Weir, B. S., Wijayawardene, N. N., Xia, J. W., Yanez-Morales, M. J., Yurkov, A., Zamora, Juan Carlos, Zare, R., Zhang, C. L., Thines, M., Crous, P. W., Lombard, L., Sandoval-Denis, M., Seifert, K. A., Schroers, H-J, Chaverri, P., Gene, J., Guarro, J., Hirooka, Y., Bensch, K., Kema, G. H. J., Lamprecht, S. C., Cai, L., Rossman, A. Y., Stadler, M., Summerbell, R. C., Taylor, J. W., Ploch, S., Visagie, C. M., Yilmaz, N., Frisvad, J. C., Abdel-Azeem, A. M., Abdollahzadeh, J., Abdolrasouli, A., Akulov, A., Alberts, J. F., Araujo, J. P. M., Ariyawansa, H. A., Bakhshi, M., Bendiksby, M., Amor, A. Ben Hadj, Bezerra, J. D. P., Boekhout, T., Camara, M. P. S., Carbia, M., Cardinali, G., Castaneda-Ruiz, R. F., Celis, A., Chaturvedi, V, Collemare, J., Croll, D., Damm, U., Decock, C. A., de Vries, R. P., Ezekiel, C. N., Fan, X. L., Fernandez, N. B., Gaya, E., Gonzalez, C. D., Gramaje, D., Groenewald, J. Z., Grube, M., Guevara-Suarez, M., Gupta, V. K., Guarnaccia, V, Haddaji, A., Hagen, F., Haelewaters, D., Hansen, K., Hashimoto, A., Hernandez-Restrepo, M., Houbraken, J., Hubka, V, Hyde, K. D., Iturriaga, T., Jeewon, R., Johnston, P. R., Jurjevic, Z., Karalti, I, Korsten, L., Kuramae, E. E., Kusan, I, Labuda, R., Lawrence, D. P., Lee, H. B., Lechat, C., Li, H. Y., Litovka, Y. A., Maharachchikumbura, S. S. N., Marin-Felix, Y., Kemkuignou, B. Matio, Matocec, N., McTaggart, A. R., Mlcoch, P., Mugnai, L., Nakashima, C., Nilsson, R. H., Noumeur, S. R., Pavlov, I. N., Peralta, M. P., Phillips, A. J. L., Pitt, J. , I, Polizzi, G., Quaedvlieg, W., Rajeshkumar, K. C., Restrepo, S., Rhaiem, A., Robert, J., Robert, V, Rodrigues, A. M., Salgado-Salazar, C., Samson, R. A., Santos, A. C. S., Shivas, R. G., Souza-Motta, C. M., Sun, G. Y., Swart, W. J., Szoke, S., Tan, Y. P., Taylor, J. E., Taylor, P. W. J., Tiago, P. , V, Vaczy, K. Z., van de Wiele, N., van der Merwe, N. A., Verkley, G. J. M., Vieira, W. A. S., Vizzini, A., Weir, B. S., Wijayawardene, N. N., Xia, J. W., Yanez-Morales, M. J., Yurkov, A., Zamora, Juan Carlos, Zare, R., Zhang, C. L., and Thines, M.
- Abstract
Recent publications have argued that there are potentially serious consequences for researchers in recognising distinct genera in the terminal fusarioid clade of the family Nectriaceae. Thus, an alternate hypothesis, namely a very broad concept of the genus Fusarium was proposed. In doing so, however, a significant body of data that supports distinct genera in Nectriaceae based on morphology, biology, and phylogeny is disregarded. A DNA phylogeny based on 19 orthologous protein-coding genes was presented to support a very broad concept of Fusarium at the F1 node in Nectriaceae. Here, we demonstrate that re-analyses of this dataset show that all 19 genes support the F3 node that represents Fusarium sensu stricto as defined by F. sambucinum (sexual morph synonym Gibberella pulicaris). The backbone of the phylogeny is resolved by the concatenated alignment, but only six of the 19 genes fully support the F1 node, representing the broad circumscription of Fusarium. Furthermore, a re-analysis of the concatenated dataset revealed alternate topologies in different phylogenetic algorithms, highlighting the deep divergence and unresolved placement of various Nectriaceae lineages proposed as members of Fusarium. Species of Fusarium s. str. are characterised by Gibberella sexual morphs, asexual morphs with thin- or thick-walled macroconidia that have variously shaped apical and basal cells, and trichothecene mycotoxin production, which separates them from other fusarioid genera. Here we show that the Wollenweber concept of Fusarium presently accounts for 20 segregate genera with clear-cut synapomorphic traits, and that fusarioid macroconidia represent a character that has been gained or lost multiple times throughout Nectriaceae. Thus, the very broad circumscription of Fusarium is blurry and without apparent synapomorphies, and does not include all genera with fusarium-like macroconidia, which are spread throughout Nectriaceae (e.g., Cosmosporella, Macroconia, Microcera). In th
- Published
- 2021
- Full Text
- View/download PDF
218. Lepto-axiogenesis
- Author
-
Co, RT, Co, RT, Fernandez, N, Ghalsasi, A, Hall, LJ, Harigaya, K, Co, RT, Co, RT, Fernandez, N, Ghalsasi, A, Hall, LJ, and Harigaya, K
- Abstract
We propose a baryogenenesis mechanism that uses a rotating condensate of a Peccei-Quinn (PQ) symmetry breaking field and the dimension-five operator that gives Majorana neutrino masses. The rotation induces charge asymmetries for the Higgs boson and for lepton chirality through sphaleron processes and Yukawa interactions. The dimension-five interaction transfers these asymmetries to the lepton asymmetry, which in turn is transferred into the baryon asymmetry through the electroweak sphaleron process. QCD axion dark matter can be simultaneously produced by dynamics of the same PQ field via kinetic misalignment or parametric resonance, favoring an axion decay constant fa ≲ 1010 GeV, or by conventional misalignment and contributions from strings and domain walls with fa ∼ 1011 GeV. The size of the baryon asymmetry is tied to the mass of the PQ field. In simple supersymmetric theories, it is independent of UV parameters and predicts the supersymmtry breaking mass scale to be O(10 − 104) TeV, depending on the masses of the neutrinos and whether the condensate is thermalized during a radiation or matter dominated era. The high supersymmetry breaking mass scale may be free from cosmological and flavor/CP problems. We also construct a theory where TeV scale supersymmetry is possible. Parametric resonance may give warm axions, and the radial component of the PQ field may give signals in rare kaon decays from mixing with the Higgs and in dark radiation.
- Published
- 2021
219. Results of development and application of an objective structured clinical examination: A pioneering experience in pharmaceutical care
- Author
-
Zarzuelo, MJ, Valverde-Merino, MI, Fernandez-Rodriguez, M, Amador-Fernandez, N, Uribe-Sanchez, A, Gomez-Guzman, M, Martinez-Martinez, F, Zarzuelo, MJ, Valverde-Merino, MI, Fernandez-Rodriguez, M, Amador-Fernandez, N, Uribe-Sanchez, A, Gomez-Guzman, M, and Martinez-Martinez, F
- Abstract
Objectives: Objective Structured Clinical Examination (OSCE) is a tool to assess skills and competencies and it can be relevant in Pharmacy studies and more specifically in Pharmaceutical Care (PC) to develop more practical and useful skills in the working life of a healthcare professional. Design and Methods: A prospective study was performed by students of the subject of PC in the Bachelor of Pharmacy and by students from the Master in PC, at the end of their classes. Five stations with standardized patients and written records were designed. A checklist was prepared in each station with various components to evaluate competencies and a questionnaire to explore students´ opinion was designed. Results: The mean of the global punctuation was 65.17±11.30/100, being higher for the Master student than Bachelor. 85.10% of students passed the exam. The best scored station by the students was the one of “Adherence” and the worst were both the written stations (“Dispensing Record” and “Medication Review Follow-up”). The best competency was technique. The activity was valued very positively according to the global score of the opinion questionnaire (4.50±0.50/5). Conclusion: Pharmacists must boost their skills and abilities required to perform pharmacy services. The use of OSCE represents a new tool to encourage and evaluate these PC skills.
- Published
- 2021
220. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
- Author
-
Pagano, L., Salmanton-Garcia, J., Marchesi, F., Busca, A., Corradini, P., Hoenigl, M., Klimko, N., Koehler, P., Pagliuca, A., Passamonti, F., Verga, L., Visek, B., Ilhan, O., Nadali, G., Weinbergerova, B., Cordoba-Mascunano, R., Marchetti, M., Collins, G. P., Farina, F., Cattaneo, C., Cabirta, A., Gomes-Silva, M., Itri, F., van Doesum, J., Ledoux, M. -P., Cernan, M., Jaksic, O., Duarte, R. F., Magliano, G., Omrani, A. S., Fracchiolla, N. S., Kulasekararaj, A., Valkovic, T., Poulsen, C. B., Machado, M., Glenthoj, A., Stoma, I., Racil, Z., Piukovics, K., Navratil, M., Emarah, Z., Sili, U., Maertens, J., Blennow, O., Bergantim, R., Garcia-Vidal, C., Prezioso, L., Guidetti, A., del Principe, M. I., Popova, M., de Jonge, N., Ormazabal-Velez, I., Fernandez, N., Falces-Romero, I., Cuccaro, A., Meers, S., Buquicchio, C., Antic, D., Al-Khabori, M., Garcia-Sanz, R., Biernat, M. M., Tisi, M. C., Sal, E., Rahimli, L., Colovic, N., Schonlein, M., Calbacho, M., Tascini, C., Miranda-Castillo, C., Khanna, N., Mendez, G. -A., Petzer, V., Novak, J., Besson, C., Dulery, R., Lamure, S., Nucci, M., Zambrotta, G., Zak, P., Seval, G. C., Bonuomo, V., Mayer, J., Lopez-Garcia, A., Sacchi, M. V., Booth, S., Ciceri, F., Oberti, M., Salvini, M., Izuzquiza, M., Nunes-Rodrigues, R., Ammatuna, E., Obr, A., Herbrecht, R., Nunez-Martin-Buitrago, L., Mancini, V., Shwaylia, H., Sciume, M., Essame, J., Nygaard, M., Batinic, J., Gonzaga, Y., Regalado-Artamendi, I., Karlsson, L. K., Shapetska, M., Hanakova, M., El-Ashwah, S., Borbenyi, Z., Colak, G. M., Nordlander, A., Dragonetti, G., Maraglino, A. M. E., Rinaldi, A., De Ramon-Sanchez, C., Cornely, O. A., Finizio, O., Fazzi, R., Sapienza, G., Chauchet, A., Van Praet, J., Prattes, J., Dargenio, M., Rossi, C., Shirinova, A., Malak, S., Tafuri, A., Ommen, H. -B., Bologna, S., Khedr, R. A., Choquet, S., Joly, B., Ceesay, M. M., Philippe, L., Kho, C. S., Desole, M., Tsirigotis, P., Otasevic, V., Borducchi, D. M. M., Antoniadou, A., Gaziev, J., Almaslamani, M. A., Garcia-Pouton, N., Paterno, G., Torres-Lopez, A., Tarantini, G., Mellinghoff, S., Grafe, S., Borschel, N., Passweg, J., Merelli, M., Barac, A., Wolf, D., Shaikh, M. U., Thieblemont, C., Bernard, S., Funke, V. A. M., Daguindau, E., Khostelidi, S., Nucci, F. M., Martin-Gonzalez, J. -A., Landau, M., Soussain, C., Laureana, C., Lacombe, K., Kohn, M., Aliyeva, G., Piedimonte, M., Fouquet, G., Rego, M., Hoell-Neugebauer, B., Cartron, G., Pinto, F., Alburquerque, A. M., Passos, J., Yilmaz, A. F., Redondo-Izal, A. -M., Altuntas, F., Heath, C., Kolditz, M., Schalk, E., Guolo, F., Karthaus, M., Della Pepa, R., Vinh, D., Noel, N., Deau Fischer, B., Drenou, B., Mitra, M. E., Meletiadis, J., Bilgin, Y. M., Jindra, P., Espigado, I., Drgona, L., Serris, A., Di Blasi, R., Ali, N., Pagano L. (ORCID:0000-0001-8287-928X), Dragonetti G., Pagano, L., Salmanton-Garcia, J., Marchesi, F., Busca, A., Corradini, P., Hoenigl, M., Klimko, N., Koehler, P., Pagliuca, A., Passamonti, F., Verga, L., Visek, B., Ilhan, O., Nadali, G., Weinbergerova, B., Cordoba-Mascunano, R., Marchetti, M., Collins, G. P., Farina, F., Cattaneo, C., Cabirta, A., Gomes-Silva, M., Itri, F., van Doesum, J., Ledoux, M. -P., Cernan, M., Jaksic, O., Duarte, R. F., Magliano, G., Omrani, A. S., Fracchiolla, N. S., Kulasekararaj, A., Valkovic, T., Poulsen, C. B., Machado, M., Glenthoj, A., Stoma, I., Racil, Z., Piukovics, K., Navratil, M., Emarah, Z., Sili, U., Maertens, J., Blennow, O., Bergantim, R., Garcia-Vidal, C., Prezioso, L., Guidetti, A., del Principe, M. I., Popova, M., de Jonge, N., Ormazabal-Velez, I., Fernandez, N., Falces-Romero, I., Cuccaro, A., Meers, S., Buquicchio, C., Antic, D., Al-Khabori, M., Garcia-Sanz, R., Biernat, M. M., Tisi, M. C., Sal, E., Rahimli, L., Colovic, N., Schonlein, M., Calbacho, M., Tascini, C., Miranda-Castillo, C., Khanna, N., Mendez, G. -A., Petzer, V., Novak, J., Besson, C., Dulery, R., Lamure, S., Nucci, M., Zambrotta, G., Zak, P., Seval, G. C., Bonuomo, V., Mayer, J., Lopez-Garcia, A., Sacchi, M. V., Booth, S., Ciceri, F., Oberti, M., Salvini, M., Izuzquiza, M., Nunes-Rodrigues, R., Ammatuna, E., Obr, A., Herbrecht, R., Nunez-Martin-Buitrago, L., Mancini, V., Shwaylia, H., Sciume, M., Essame, J., Nygaard, M., Batinic, J., Gonzaga, Y., Regalado-Artamendi, I., Karlsson, L. K., Shapetska, M., Hanakova, M., El-Ashwah, S., Borbenyi, Z., Colak, G. M., Nordlander, A., Dragonetti, G., Maraglino, A. M. E., Rinaldi, A., De Ramon-Sanchez, C., Cornely, O. A., Finizio, O., Fazzi, R., Sapienza, G., Chauchet, A., Van Praet, J., Prattes, J., Dargenio, M., Rossi, C., Shirinova, A., Malak, S., Tafuri, A., Ommen, H. -B., Bologna, S., Khedr, R. A., Choquet, S., Joly, B., Ceesay, M. M., Philippe, L., Kho, C. S., Desole, M., Tsirigotis, P., Otasevic, V., Borducchi, D. M. M., Antoniadou, A., Gaziev, J., Almaslamani, M. A., Garcia-Pouton, N., Paterno, G., Torres-Lopez, A., Tarantini, G., Mellinghoff, S., Grafe, S., Borschel, N., Passweg, J., Merelli, M., Barac, A., Wolf, D., Shaikh, M. U., Thieblemont, C., Bernard, S., Funke, V. A. M., Daguindau, E., Khostelidi, S., Nucci, F. M., Martin-Gonzalez, J. -A., Landau, M., Soussain, C., Laureana, C., Lacombe, K., Kohn, M., Aliyeva, G., Piedimonte, M., Fouquet, G., Rego, M., Hoell-Neugebauer, B., Cartron, G., Pinto, F., Alburquerque, A. M., Passos, J., Yilmaz, A. F., Redondo-Izal, A. -M., Altuntas, F., Heath, C., Kolditz, M., Schalk, E., Guolo, F., Karthaus, M., Della Pepa, R., Vinh, D., Noel, N., Deau Fischer, B., Drenou, B., Mitra, M. E., Meletiadis, J., Bilgin, Y. M., Jindra, P., Espigado, I., Drgona, L., Serris, A., Di Blasi, R., Ali, N., Pagano L. (ORCID:0000-0001-8287-928X), and Dragonetti G.
- Abstract
Background: Patients with hematological malignancies (HM) are at high risk of mortality from SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse outcomes may improve clinical management in these patients. We therefore studied baseline characteristics of HM patients developing COVID-19 and analyzed predictors of mortality. Methods: The survey was supported by the Scientific Working Group Infection in Hematology of the European Hematology Association (EHA). Eligible for the analysis were adult patients with HM and laboratory-confirmed COVID-19 observed between March and December 2020. Results: The study sample includes 3801 cases, represented by lymphoproliferative (mainly non-Hodgkin lymphoma n = 1084, myeloma n = 684 and chronic lymphoid leukemia n = 474) and myeloproliferative malignancies (mainly acute myeloid leukemia n = 497 and myelodysplastic syndromes n = 279). Severe/critical COVID-19 was observed in 63.8% of patients (n = 2425). Overall, 2778 (73.1%) of the patients were hospitalized, 689 (18.1%) of whom were admitted to intensive care units (ICUs). Overall, 1185 patients (31.2%) died. The primary cause of death was COVID-19 in 688 patients (58.1%), HM in 173 patients (14.6%), and a combination of both COVID-19 and progressing HM in 155 patients (13.1%). Highest mortality was observed in acute myeloid leukemia (199/497, 40%) and myelodysplastic syndromes (118/279, 42.3%). The mortality rate significantly decreased between the first COVID-19 wave (March–May 2020) and the second wave (October–December 2020) (581/1427, 40.7% vs. 439/1773, 24.8%, p value < 0.0001). In the multivariable analysis, age, active malignancy, chronic cardiac disease, liver disease, renal impairment, smoking history, and ICU stay correlated with mortality. Acute myeloid leukemia was a higher mortality risk than lymphoproliferative diseases. Conclusions: This survey confirms that COVID-19 patients with HM are at high risk of lethal complications. Ho
- Published
- 2021
221. Fusarium: more than a node or a foot-shaped basal cell
- Author
-
Universitat Rovira i Virgili, Crous, P. W.; Lombard, L.; Sandoval-Denis, M.; Seifert, K. A.; Schroers, H-J; Chaverri, P.; Gene, J.; Guarro, J.; Hirooka, Y.; Bensch, K.; Kema, G. H. J.; Lamprecht, S. C.; Cai, L.; Rossman, A. Y.; Stadler, M.; Summerbell, R. C.; Taylor, J. W.; Ploch, S.; Visagie, C. M.; Yilmaz, N.; Frisvad, J. C.; Abdel-Azeem, A. M.; Abdollahzadeh, J.; Abdolrasouli, A.; Akulov, A.; Alberts, J. F.; Araujo, J. P. M.; Ariyawansa, H. A.; Bakhshi, M.; Bendiksby, M.; Amor, A. Ben Hadj; Bezerra, J. D. P.; Boekhout, T.; Camara, M. P. S.; Carbia, M.; Cardinali, G.; Castaneda-Ruiz, R. F.; Celis, A.; Chaturvedi, V; Collemare, J.; Croll, D.; Damm, U.; Decock, C. A.; de Vries, R. P.; Ezekiel, C. N.; Fan, X. L.; Fernandez, N. B.; Gaya, E.; Gonzalez, C. D.; Gramaje, D.; Groenewald, J. Z.; Grube, M.; Guevara-Suarez, M.; Gupta, V. K.; Guarnaccia, V; Haddaji, A.; Hagen, F.; Haelewaters, D.; Hansen, K.; Hashimoto, A.; Hernandez-Restrepo, M.; Houbraken, J.; Hubka, V; Hyde, K. D.; Iturriaga, T.; Jeewon, R.; Johnston, P. R.; Jurjevic, Z.; Karalti, I; Korsten, L.; Kuramae, E. E.; Kusan, I; Labuda, R.; Lawrence, D. P.; Lee, H. B.; Lechat, C.; Li, H. Y.; Litovka, Y. A.; Maharachchikumbura, S. S. N.; Marin-Felix, Y.; Kemkuignou, B. Matio; Matocec, N.; McTaggart, A. R.; Mlcoch, P.; Mugnai, L.; Nakashima, C.; Nilsson, R. H.; Noumeur, S. R.; Pavlov, I. N.; Peralta, M. P.; Phillips, A. J. L.; Pitt, J., I; Polizzi, G.; Quaedvlieg, W.; Rajeshkumar, K. C.; Restrepo, S.; Rhaiem, A.; Robert, J.; Robert, V; Rodrigues, A. M.; Salgado-Salazar, C.; Samson, R. A.; Santos, A. C. S.; Shivas, R. G.; Souza-Motta, C. M.; Sun, G. Y.; Swart, W. J.; Szoke, S.; Tan, Y. P.; Taylor, J. E.; Taylor, P. W. J.; Tiago, P., V; Vaczy, K. Z.; van de Wiele, N.; van der Merwe, N. A.; Verkley, G. J. M.; Vieira, W. A. S.; Vizzini, A.; Weir, B. S., Universitat Rovira i Virgili, and Crous, P. W.; Lombard, L.; Sandoval-Denis, M.; Seifert, K. A.; Schroers, H-J; Chaverri, P.; Gene, J.; Guarro, J.; Hirooka, Y.; Bensch, K.; Kema, G. H. J.; Lamprecht, S. C.; Cai, L.; Rossman, A. Y.; Stadler, M.; Summerbell, R. C.; Taylor, J. W.; Ploch, S.; Visagie, C. M.; Yilmaz, N.; Frisvad, J. C.; Abdel-Azeem, A. M.; Abdollahzadeh, J.; Abdolrasouli, A.; Akulov, A.; Alberts, J. F.; Araujo, J. P. M.; Ariyawansa, H. A.; Bakhshi, M.; Bendiksby, M.; Amor, A. Ben Hadj; Bezerra, J. D. P.; Boekhout, T.; Camara, M. P. S.; Carbia, M.; Cardinali, G.; Castaneda-Ruiz, R. F.; Celis, A.; Chaturvedi, V; Collemare, J.; Croll, D.; Damm, U.; Decock, C. A.; de Vries, R. P.; Ezekiel, C. N.; Fan, X. L.; Fernandez, N. B.; Gaya, E.; Gonzalez, C. D.; Gramaje, D.; Groenewald, J. Z.; Grube, M.; Guevara-Suarez, M.; Gupta, V. K.; Guarnaccia, V; Haddaji, A.; Hagen, F.; Haelewaters, D.; Hansen, K.; Hashimoto, A.; Hernandez-Restrepo, M.; Houbraken, J.; Hubka, V; Hyde, K. D.; Iturriaga, T.; Jeewon, R.; Johnston, P. R.; Jurjevic, Z.; Karalti, I; Korsten, L.; Kuramae, E. E.; Kusan, I; Labuda, R.; Lawrence, D. P.; Lee, H. B.; Lechat, C.; Li, H. Y.; Litovka, Y. A.; Maharachchikumbura, S. S. N.; Marin-Felix, Y.; Kemkuignou, B. Matio; Matocec, N.; McTaggart, A. R.; Mlcoch, P.; Mugnai, L.; Nakashima, C.; Nilsson, R. H.; Noumeur, S. R.; Pavlov, I. N.; Peralta, M. P.; Phillips, A. J. L.; Pitt, J., I; Polizzi, G.; Quaedvlieg, W.; Rajeshkumar, K. C.; Restrepo, S.; Rhaiem, A.; Robert, J.; Robert, V; Rodrigues, A. M.; Salgado-Salazar, C.; Samson, R. A.; Santos, A. C. S.; Shivas, R. G.; Souza-Motta, C. M.; Sun, G. Y.; Swart, W. J.; Szoke, S.; Tan, Y. P.; Taylor, J. E.; Taylor, P. W. J.; Tiago, P., V; Vaczy, K. Z.; van de Wiele, N.; van der Merwe, N. A.; Verkley, G. J. M.; Vieira, W. A. S.; Vizzini, A.; Weir, B. S.
- Abstract
Microbiology, Forestry and Agricultural Biotechnology Institute (FABI), Faculty of Natural and Agricultural Sciences, University of Pretoria, P. Bag X20, Hatfield, 0028, Pretoria, South Africa; 20Department of Biotechnology and Biomedicine, DTU-Bioengineering, Technical University of Denmark, 2800, Kongens Lyngby, Denmark; 21Systematic Mycology Lab., Botany and Microbiology Department, Faculty of Science, Suez Canal University, Ismailia, 41522, Egypt; 22Department of Plant Protection, Faculty of Agriculture, University of Kurdistan, P.O. Box 416, Sanandaj, Iran; 23Department of Medical Microbiology, King's College Hospital, London, UK;24Department of Infectious Diseases, Imperial College London, London, UK;25Department of Mycology and Plant Resistance, V. N. Karazin Kharkiv National University, Maidan Svobody 4, 61022, Kharkiv, Ukraine; 26Department of Food Science and Technology, Cape Peninsula University of Technology, P.O. Box 1906, Bellville, 7535, South Africa; 27School of Forest Resources and Conservation, University of Florida, Gainesville, FL, USA; 28Department of Plant Pathology and Microbiology, College of Bio-Resources and Agriculture, National Taiwan University, No.1, Sec.4, Roosevelt Road, Taipei, 106, Taiwan, ROC
- Published
- 2021
222. 2142P Criteria for the choice of therapeutic ceiling in the hospitalized oncology patient: Healthcare impact of the multidisciplinary committee with the Intensive Care Unit (ICU)
- Author
-
García, M.E. Guirao, Canovas, M. Sanchez, Saura, A. Sanchez, Luis, S. Montenegro, Ivars, M.A., Boluda, N. Blaya, Fernández, N. Alonso, Quintana, E. Martínez, García, M. Cerón, García, L. López, Delis, P.S. Bayoumy, Alcaraz, A. Carrillo, and de la Pena, F. Ayala
- Published
- 2023
- Full Text
- View/download PDF
223. 1602P Simulation training for compassionate extubation in the pediatric intensive care unit
- Author
-
Fernandez, N.
- Published
- 2023
- Full Text
- View/download PDF
224. Performance evaluation of an anaerobic fluidized bed reactor with natural zeolite as support material when treating high-strength distillery wastewater
- Author
-
Fernández, N., Montalvo, S., Borja, R., Guerrero, L., Sánchez, E., Cortés, I., Colmenarejo, M.F., Travieso, L., and Raposo, F.
- Published
- 2008
- Full Text
- View/download PDF
225. Detección de víctimas de bullying en un centro de Atención Primaria
- Author
-
de Miguel Vicenti, M., Benito Ortiz, L., Reyes Fernández, N., Pedraz García, M.I., Martín Redondo, B., and Olivares Ortiz, J.
- Published
- 2008
- Full Text
- View/download PDF
226. Analgesia acupuntural en cirugía de catarata en el Hospital Miguel Enríquez (2005)
- Author
-
Zozaya Aldana, B., Medina-Rodríguez, I., Santana Pons, J.L., and González Fernández, N.
- Published
- 2008
- Full Text
- View/download PDF
227. Dose response of lactating dairy ewes during suckling and milking to bovine somatotropin
- Author
-
Requena, R., Balasch, S., Peris, C., Rodriguez, M., and Fernandez, N.
- Subjects
Bovine somatotropin -- Physiological aspects ,Milk production -- Management ,Ewes -- Physiological aspects ,Company business management ,Zoology and wildlife conservation - Abstract
The objectives were to determine the effect of administering recombinant bovine ST (bST) every 14 d on milk yield and milk composition in dairy ewes and to assess the possible effects of treatment on milk yield loss that occurs at lamb weaning. Seventy-two lactating dairy ewes were separated into 4 groups at lambing, and each group received no bST (control) or 40, 80, or 120 mg of bST every 14 d until wk 20 of lactation. During the first 5 wk of lactation, ewes suckled their lambs during the night and were milked once daily (period 1). After weaning, from 6 to 22 wk of lactation, ewes were exclusively milked twice daily (period 2). Actual milk yield, potential milk yield, and milk component percentages were recorded weekly throughout lactation. In period 1, bST-treated groups increased yields of potential milk (P = 0.04) and the corresponding 6% fat-corrected milk (FCM; P = 0.04) but not actual milk yield (P = 0.42) compared with the untreated group. In period 2, treated groups increased potential (P < 0.01) and actual (P < 0.01) milk yields as well as their corresponding 6% FCM (potential, P < 0.01; actual, P < 0.01), in comparison with the untreated group. The group treated with 120 mg of bST every 14 d yielded 39% more actual milk and 44% more 6% FCM than the control group for period 2. At weaning, between the last week of period 1 and the first week of period 2, treated groups showed similar absolute (P = 0.15) and relative (P = 0.33) values for the potential milk losses compared with the control group. Treatments increased (P = 0.04) actual milk fat percentages during period 1, but did not affect the other milk components or somatic cell count. In summary, bST increased potential milk yield throughout lactation and actual milk yield only after weaning in dairy ewes. In dairy ewes, bST was not useful for reducing the milk yield loss that occurred at weaning. Key words: dairy ewe, milk composition, milk yield, somatotropin, weaning doi: 10.2527/jas.2009-2690
- Published
- 2010
228. Relapse rates in chronic hepatitis B naïve patients after discontinuation of antiviral therapy with entecavir
- Author
-
Ridruejo, E., Marciano, S., Galdame, O., Reggiardo, M. V., Muñoz, A. E., Adrover, R., Cocozzella, D., Fernandez, N., Estepo, C., Mendizábal, M., Romero, G. A., Levi, D., Schroder, T., Paz, S., Fainboim, H., Mandó, O. G., Gadano, A. C., and Silva, M. O.
- Published
- 2014
- Full Text
- View/download PDF
229. Fold patterns and multilayer rheology of the Lurestan Province, Zagros Simply Folded Belt (Iran)
- Author
-
Casciello, E., Verges, J., Saura, E., Casini, G., Fernandez, N., Blanc, E., Homke, S., and Hunt, D.W.
- Subjects
Iran -- Environmental aspects ,Anticlines -- Natural history ,Geology, Structural -- Research ,Earth sciences - Abstract
Anticlines of the Lurestan Province in the Zagros fold--thrust belt have been studied by integrating field-based analysis with the use of high-resolution satellite images and data available from the literature. The distribution of folds in the southeastern Lurestan Province, expressed in terms of axial length and wavelength distribution, shows a direct link with the characteristics of the sedimentary multilayer in which the folds developed. Within the carbonate deposits of the Late Cretaceous Bangestan Group the transition from pelagic to neritic facies determines a threefold increase in anticline spacing and promotes the development of thrust structures in the forelimb of anticlines. The Oligocene--Miocene Shahbazan--Asmari unit folds harmonically with the Bangestan Group, except in the areas where the Palaeogene deposits interposed between the two units exceed 1300 m of thickness. In these areas the Shahbazan--Asmari carbonates display short-wavelength folds indicating a complete decoupling from the underlying folds of the Bangestan Group. It is suggested that this decoupling occurs because the summed thickness of the incompetent units separating the two carbonate units exceeds the extension of the zone of effective contact strain of the Bangestan Group folds.
- Published
- 2009
230. 4CPS-260 Analysis of drugs interactions between coronavirus (COVID-19) antiviral treatment and concomitant medication
- Author
-
Castillejo, R, primary, Martin Fernandez, N, additional, Beltran Garcia, M, additional, Martinez Suarez, A, additional, Rendon De Lope, L, additional, and Sandoval Fernandez Del Castillo, S, additional
- Published
- 2021
- Full Text
- View/download PDF
231. Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP)
- Author
-
Vincent, J, Lefrant, J, Kotfis, K, Nanchal, R, Martin-Loeches, I, Wittebole, X, Sakka, S, Pickkers, P, Moreno, R, Sakr, Y, Pavlik, P, Manak, J, Kieslichova, E, Turek, R, Fischer, M, Valkova, R, Dadak, L, Dostal, P, Malaska, J, Hajek, R, Zidkova, A, Lavicka, P, Medve, L, Sarkany, A, Kremer, I, Marjanek, Z, Tamasi, P, Kolbusz, J, Kubler, A, Mielczarek, B, Mikaszewska-Sokolewicz, M, Tamowicz, B, Sulkowski, W, Smuszkiewicz, P, Pihowicz, A, Trejnowska, E, Hagau, N, Filipescu, D, Droc, G, Lupu, M, Nica, A, Stoica, R, Tomescu, D, Constantinescu, D, Valcoreanu Zbaganu, G, Slavcovici, A, Soskic, L, Palibrk, I, Jankovic, R, Jovanovic, B, Pandurovic, M, Bumbasirevic, V, Uljarevic, B, Surbatovic, M, Ladjevic, N, Slobodianiuk, G, Sobona, V, Cikova, A, Gebhardtova, A, Cohen, J, Sold, O, Urbanek, P, Schlieber, J, Reisinger, J, Auer, J, Hartjes, A, Lerche, A, Janous, T, Kink, E, Krahulec, W, Smolle, K, Van Der Schueren, M, Thibo, P, Vanhoof, M, Ahmet, I, Philippe, G, Dufaye, P, Jacobs, O, Fraipont, V, Biston, P, Dive, A, Bouckaert, Y, Gilbert, E, Gressens, B, Pinck, E, Collin, V, De Waele, J, Rimachi, R, Gusu, D, De Decker, K, Mandianga, K, Heytens, L, Herbert, S, Olivier, V, Vandenheede, W, Rogiers, P, Kolodzeike, P, Kruse, M, Andersen, T, Harjola, V, Saarinen, K, Leone, M, Durocher, A, Moulront, S, Lepape, A, Losser, M, Cabaret, P, Kalaitzis, E, Zogheib, E, Charve, P, Francois, B, Beilouny, B, Forceville, X, Misset, B, Jacobs, F, Bernard, F, Payen, D, Wynckel, A, Castelain, V, Faure, A, Lavagne, P, Thierry, L, Moussa, M, Vieillard-Baron, A, Durand, M, Gainnier, M, Ichai, C, Arens, S, Hoffmann, C, Kaffarnik, M, Scharnofske, C, Voigt, I, Peckelsen, C, Weber, M, Gille, J, Lange, A, Schoser, G, Sablotzki, A, Jaschinski, U, Bluethgen, A, Vogel, F, Tscheu, A, Fuchs, T, Wattenberg, M, Helmes, T, Scieszka, S, Heintz, M, Kohler, J, Fiedler, F, Danz, M, Riessen, R, Kerz, T, Kersten, A, Tacke, F, Marx, G, Volkert, T, Schmutz, A, Nierhaus, A, Kluge, S, Abel, P, Janosi, R, Utzolino, S, Bracht, H, Toussaint, S, Giannakou Peftoulidou, M, Myrianthefs, P, Armaganidis, A, Routsi, C, Xini, A, Mouloudi, E, Kokoris, I, Kyriazopoulos, G, Vlachos, S, Lavrentieva, A, Partala, P, Nakos, G, Barry, J, O'Leary, R, Motherway, C, Faheem, M, Dunne, E, Donnelly, M, Konrad, T, Bonora, E, Achilli, C, Rossi, S, Castiglione, G, Peris, A, Albanese, D, Stocchetti, N, Citerio, G, Mozzoni, L, Sisillo, E, De Negri, P, Savioli, M, Vecchiarelli, P, Puflea, F, Stankovic, V, Minoja, G, Montibeller, S, Calligaro, P, Sorrentino, R, Feri, M, Zambon, M, Colombaroli, E, Giarratano, A, Pellis, T, Capra, C, Antonelli, M, Gullo, A, Chelazzi, C, De Capraris, A, Patroniti, N, Girardis, M, Franchi, F, Berlot, G, Ponssen, H, Ten Cate, J, Bormans, L, Husada, S, Buise, M, Van Der Hoven, B, Reidinga, A, Kuiper, M, Kluge, G, Den Boer, S, Kesecioglu, J, Van Leeuwen, H, Flaatten, H, Mo, S, Branco, V, Rua, F, Lafuente, E, Sousa, M, Catorze, N, Barros, M, Pereira, L, Vintem De Oliveira, A, Gomes, J, Gaspar, I, Pereira, M, Cymbron, M, Dias, A, Almeida, E, Beirao, S, Serra, I, Ribeiro, R, Povoa, P, Faria, F, Costa-E-Silva, Z, Nobrega, J, Fernandes, F, Gabriel, J, Voga, G, Rupnik, E, Kosec, L, Kerin Povsic, M, Osojnik, I, Tomic, V, Sinkovic, A, Gonzalez, J, Zavala, E, Perez Valenzuela, J, Marina, L, Vidal-Cortes, P, Posada, P, Ignacio Martin-Loeches, A, Munoz Guillen, N, Palomar, M, Sole-Violan, J, Torres, A, Gonzalez Gallego, M, Aguilar, G, Montoiro Allue, R, Argueso, M, Parejo, M, Palomo Navarro, M, Jose, A, Nin, N, Alvarez Lerma, F, Martinez, O, Tenza Lozano, E, Arenal Lopez, S, Perez Granda, M, Moreno, S, Llubia, C, De La Fuente Martos, C, Gonzalez-Arenas, P, Llamas Fernandez, N, Gil Rueda, B, Estruch Pons, I, Cruza, N, Maroto, F, Estella, A, Ferrer, A, Iglesias Fraile, L, Quindos, B, Quintano, A, Tebar, M, Cardinal, P, Reyes, A, Rodriguez, A, Abella, A, Garcia Del Valle, S, Yus, S, Maseda, E, Berezo, J, Tejero Pedregosa, A, Laplaza, C, Ferrer, R, Rico-Feijoo, J, Rodriguez, M, Monedero, P, Eriksson, K, Lind, D, Chabanel, D, Zender, H, Heer, K, Frankenberger, B, Jakob, S, Haller, A, Mathew, S, Downes, R, Barrera Groba, C, Johnston, A, Meacher, R, Keays, R, Haji-Michael, P, Tyler, C, Ferguson, A, Jones, S, Tyl, D, Ball, A, Vogel, J, Booth, M, Downie, P, Watters, M, Brett, S, Garfield, M, Everett, L, Heenen, S, Dhir, S, Beardow, Z, Mostert, M, Brosnan, S, Pinto, N, Harris, S, Summors, A, Andrew, N, Rose, A, Appelboam, R, Davies, O, Vickers, E, Agarwal, B, Szakmany, T, Wimbush, S, Welters, I, Pearse, R, Hollands, R, Kirk-Bayley, J, Fletcher, N, Bray, B, Brealey, D, Delle Karth, G, Draxler, V, Filzwieser, G, Heindl, W, Kellner, G, Lenz, K, Rossmann, E, Wiedermann, C, Chochrad, D, Damas, P, Decruyenaere, J, Hoste, E, Devriendt, J, Espeel, B, Installe, E, Malbrain, M, Nollet, G, Preiser, J, Raemaekers, J, Roman, A, Simon, M, Spapen, H, Swinnen, W, Vallot, F, Chytra, I, Herold, I, Polak, F, Sterba, M, Bestle, M, Espersen, K, Guldager, H, Welling, K, Nyman, D, Ruokonen, E, Annane, D, Catogni, P, Colas, G, Coulomb, F, Dorne, R, Garrouste, M, Isetta, C, Larche, J, Legall, J, Lessire, H, Malledant, Y, Mateu, P, Ossart, M, Schlossmacher, P, Timsit, J, Winnock, S, Sollet, J, Mallet, L, Maurer, P, Sab, J, Aykut, G, Brunkhorst, F, Lauterbach, M, Ragaller, M, Gatz, R, Gerlach, H, Henzler, D, Hopf, H, Hueneburg, H, Karzai, W, Keller, A, Bauer, T, Kuhlmann, U, Langgartner, J, Manhold, C, Reith, B, Schuerholz, T, Spies, C, Stogbauer, R, Unterburger, J, Clouva-Molyvdas, P, Giokas, G, Ioannidou, E, Lahana, A, Liolios, A, Marathias, K, Tasiou, A, Tsangaris, H, Marsh, B, Power, M, Sprung, C, Biagioli, B, Bobbio Pallavicini, F, Pesenti, A, Della Corte, F, Donadio, P, Donati, A, Giorgio, T, Giudici, D, Greco, S, Guadagnucci, A, Lapichino, G, Livigni, S, Moise, G, Nardi, G, Panascia, E, Pizzamiglio, M, Ranieri, V, Rosi, R, Sicignano, A, Solca, M, Vignali, G, Volpe Rinonapoli, I, Barnas, M, De Bel, E, De Pont, A, Groeneveld, J, Nijsten, M, Sie, L, Zandstra, D, Harboe, S, Linden, S, Lovstad, R, Moen, H, Smith-Erichsen, N, Piotrowski, A, Karpel, E, Pais-De-Lacerda, A, Paiva, J, Pimentel, A, Jovanovic, K, Malik, P, Lucka, K, Aldecoa Alvarez-Santullano, C, Artigas, A, Escorsell, A, Nicolas, J, Izura Cea, J, Montejo, J, Palencia, E, Santos, F, Sierra-Camerino, R, Sipmann, F, Brodersen, K, Haggqvist, J, Hermansson, D, Hjelmqvist, H, Loderer, G, Maggiorini, M, Andrews, P, Appadu, B, Bewley, J, Burchett, K, Chambers, P, Coakley, J, Doberenz, D, Eastwood, N, Fielden, J, Gedney, J, Gunning, K, Harling, D, Jankowski, S, Jayson, D, Kilner, A, Krishna-Kumar, V, Lei, K, Mackenzie, S, Macnaughton, P, Mcculloch, C, Morgan, P, Rhodes, A, Roberts, C, Russell, M, Tupper-Carey, D, Wright, M, Twohey, L, Watts, J, Webster, R, Williams, D, Vincent J. -L., Lefrant J. -Y., Kotfis K., Nanchal R., Martin-Loeches I., Wittebole X., Sakka S. G., Pickkers P., Moreno R., Sakr Y., Pavlik P., Manak J., Kieslichova E., Turek R., Fischer M., Valkova R., Dadak L., Dostal P., Malaska J., Hajek R., Zidkova A., Lavicka P., Medve L., Sarkany A., Kremer I., Marjanek Z., Tamasi P., Kolbusz J., Kubler A., Mielczarek B., Mikaszewska-Sokolewicz M., Tamowicz B., Sulkowski W., Smuszkiewicz P., Pihowicz A., Trejnowska E., Hagau N., Filipescu D., Droc G., Lupu M., Nica A., Stoica R., Tomescu D., Constantinescu D., Valcoreanu Zbaganu G., Slavcovici A., Soskic L., Palibrk I., Jankovic R., Jovanovic B., Pandurovic M., Bumbasirevic V., Uljarevic B., Surbatovic M., Ladjevic N., Slobodianiuk G., Sobona V., Cikova A., Gebhardtova A., Cohen J., Sold O., Urbanek P., Schlieber J., Reisinger J., Auer J., Hartjes A., Lerche A., Janous T., Kink E., Krahulec W., Smolle K., Van Der Schueren M., Thibo P., Vanhoof M., Ahmet I., Philippe G., Dufaye P., Jacobs O., Fraipont V., Biston P., Dive A., Bouckaert Y., Gilbert E., Gressens B., Pinck E., Collin V., De Waele J., Rimachi R., Gusu D., De Decker K., Mandianga K., Heytens L., Herbert S., Olivier V., Vandenheede W., Rogiers P., Kolodzeike P., Kruse M., Andersen T., Harjola V., Saarinen K., Leone M., Durocher A., Moulront S., Lepape A., Losser M., Cabaret P., Kalaitzis E., Zogheib E., Charve P., Francois B., Beilouny B., Forceville X., Misset B., Jacobs F., Bernard F., Payen D., Wynckel A., Castelain V., Faure A., Lavagne P., Thierry L., Moussa M., Vieillard-Baron A., Durand M., Gainnier M., Ichai C., Arens S., Hoffmann C., Kaffarnik M., Scharnofske C., Voigt I., Peckelsen C., Weber M., Gille J., Lange A., Schoser G., Sablotzki A., Jaschinski U., Bluethgen A., Vogel F., Tscheu A., Fuchs T., Wattenberg M., Helmes T., Scieszka S., Heintz M., Sakka S., Kohler J., Fiedler F., Danz M., Riessen R., Kerz T., Kersten A., Tacke F., Marx G., Volkert T., Schmutz A., Nierhaus A., Kluge S., Abel P., Janosi R., Utzolino S., Bracht H., Toussaint S., Giannakou Peftoulidou M., Myrianthefs P., Armaganidis A., Routsi C., Xini A., Mouloudi E., Kokoris I., Kyriazopoulos G., Vlachos S., Lavrentieva A., Partala P., Nakos G., Barry J., O'Leary R., Motherway C., Faheem M., Dunne E., Donnelly M., Konrad T., Bonora E., Achilli C., Rossi S., Castiglione G., Peris A., Albanese D., Stocchetti N., Citerio G., Mozzoni L., Sisillo E., De Negri P., Savioli M., Vecchiarelli P., Puflea F., Stankovic V., Minoja G., Montibeller S., Calligaro P., Sorrentino R., Feri M., Zambon M., Colombaroli E., Giarratano A., Pellis T., Capra C., Antonelli M., Gullo A., Chelazzi C., De Capraris A., Patroniti N., Girardis M., Franchi F., Berlot G., Ponssen H., Ten Cate J., Bormans L., Husada S., Buise M., Van Der Hoven B., Reidinga A., Kuiper M., Kluge G., Den Boer S., Kesecioglu J., Van Leeuwen H., Flaatten H., Mo S., Branco V., Rua F., Lafuente E., Sousa M., Catorze N., Barros M., Pereira L., Vintem De Oliveira A., Gomes J., Gaspar I., Pereira M., Cymbron M., Dias A., Almeida E., Beirao S., Serra I., Ribeiro R., Povoa P., Faria F., Costa-E-Silva Z., Nobrega J., Fernandes F., Gabriel J., Voga G., Rupnik E., Kosec L., Kerin Povsic M., Osojnik I., Tomic V., Sinkovic A., Gonzalez J., Zavala E., Perez Valenzuela J., Marina L., Vidal-Cortes P., Posada P., Ignacio Martin-Loeches A., Munoz Guillen N., Palomar M., Sole-Violan J., Torres A., Gonzalez Gallego M., Aguilar G., Montoiro Allue R., Argueso M., Parejo M., Palomo Navarro M., Jose A., Nin N., Alvarez Lerma F., Martinez O., Tenza Lozano E., Arenal Lopez S., Perez Granda M., Moreno S., Llubia C., De La Fuente Martos C., Gonzalez-Arenas P., Llamas Fernandez N., Gil Rueda B., Estruch Pons I., Cruza N., Maroto F., Estella A., Ferrer A., Iglesias Fraile L., Quindos B., Quintano A., Tebar M., Cardinal P., Reyes A., Rodriguez A., Abella A., Garcia Del Valle S., Yus S., Maseda E., Berezo J., Tejero Pedregosa A., Laplaza C., Ferrer R., Rico-Feijoo J., Rodriguez M., Monedero P., Eriksson K., Lind D., Chabanel D., Zender H., Heer K., Frankenberger B., Jakob S., Haller A., Mathew S., Downes R., Barrera Groba C., Johnston A., Meacher R., Keays R., Haji-Michael P., Tyler C., Ferguson A., Jones S., Tyl D., Ball A., Vogel J., Booth M., Downie P., Watters M., Brett S., Garfield M., Everett L., Heenen S., Dhir S., Beardow Z., Mostert M., Brosnan S., Pinto N., Harris S., Summors A., Andrew N., Rose A., Appelboam R., Davies O., Vickers E., Agarwal B., Szakmany T., Wimbush S., Welters I., Pearse R., Hollands R., Kirk-Bayley J., Fletcher N., Bray B., Brealey D., Delle Karth G., Draxler V., Filzwieser G., Heindl W., Kellner G., Lenz K., Rossmann E., Wiedermann C., Chochrad D., Damas P., Decruyenaere J., Hoste E., Devriendt J., Espeel B., Installe E., Malbrain M., Nollet G., Preiser J. C., Raemaekers J., Roman A., Simon M., Spapen H., Swinnen W., Vallot F., Chytra I., Herold I., Polak F., Sterba M., Bestle M., Espersen K., Guldager H., Welling K. -L., Nyman D., Ruokonen E., Annane D., Catogni P., Colas G., Coulomb F., Dorne R., Garrouste M., Isetta C., Larche J., LeGall J. -R., Lessire H., Malledant Y., Mateu P., Ossart M., Schlossmacher P., Timsit J. -F., Winnock S., Sollet J. -P., Mallet L., Maurer P., Sab J. M., Aykut G., Brunkhorst F., Lauterbach M., Ragaller M., Gatz R., Gerlach H., Henzler D., Hopf H. -B., Hueneburg H., Karzai W., Keller A., Bauer T., Kuhlmann U., Langgartner J., Manhold C., Reith B., Schuerholz T., Spies C., Stogbauer R., Unterburger J., Clouva-Molyvdas P. -M., Giokas G., Ioannidou E., Lahana A., Liolios A., Marathias K., Tasiou A., Tsangaris H., Marsh B., Power M., Sprung C., Biagioli B., Bobbio Pallavicini F., Pesenti A., Della Corte F., Donadio P. P., Donati A., Giorgio T., Giudici D., Greco S., Guadagnucci A., Lapichino G., Livigni S., Moise G., Nardi G., Panascia E., Pizzamiglio M., Ranieri V. M., Rosi R., Sicignano A., Solca M., Vignali G., Volpe Rinonapoli I., Barnas M., De Bel E. E., De Pont A. -C., Groeneveld J., Nijsten M., Sie L., Zandstra D. F., Harboe S., Linden S., Lovstad R. Z., Moen H., Smith-Erichsen N., Piotrowski A., Karpel E., Pais-De-Lacerda A., Paiva J. A., Pimentel A., Jovanovic K., Malik P., Lucka K., Aldecoa Alvarez-Santullano C., Artigas A., Escorsell A., Nicolas J., Izura Cea J. J., Montejo J., Palencia E., Santos F., Sierra-Camerino R., Sipmann F., Brodersen K., Haggqvist J., Hermansson D., Hjelmqvist H., Loderer G., Maggiorini M., Andrews P., Appadu B., Bewley J., Burchett K., Chambers P., Coakley J., Doberenz D., Eastwood N., Fielden J., Gedney J., Gunning K., Harling D., Jankowski S., Jayson D., Kilner A., Krishna-Kumar V., Lei K., Mackenzie S., Macnaughton P., McCulloch C., Morgan P., Rhodes A., Roberts C., Russell M., Tupper-Carey D., Wright M., Twohey L., Watts J., Webster R., Williams D., Vincent, J, Lefrant, J, Kotfis, K, Nanchal, R, Martin-Loeches, I, Wittebole, X, Sakka, S, Pickkers, P, Moreno, R, Sakr, Y, Pavlik, P, Manak, J, Kieslichova, E, Turek, R, Fischer, M, Valkova, R, Dadak, L, Dostal, P, Malaska, J, Hajek, R, Zidkova, A, Lavicka, P, Medve, L, Sarkany, A, Kremer, I, Marjanek, Z, Tamasi, P, Kolbusz, J, Kubler, A, Mielczarek, B, Mikaszewska-Sokolewicz, M, Tamowicz, B, Sulkowski, W, Smuszkiewicz, P, Pihowicz, A, Trejnowska, E, Hagau, N, Filipescu, D, Droc, G, Lupu, M, Nica, A, Stoica, R, Tomescu, D, Constantinescu, D, Valcoreanu Zbaganu, G, Slavcovici, A, Soskic, L, Palibrk, I, Jankovic, R, Jovanovic, B, Pandurovic, M, Bumbasirevic, V, Uljarevic, B, Surbatovic, M, Ladjevic, N, Slobodianiuk, G, Sobona, V, Cikova, A, Gebhardtova, A, Cohen, J, Sold, O, Urbanek, P, Schlieber, J, Reisinger, J, Auer, J, Hartjes, A, Lerche, A, Janous, T, Kink, E, Krahulec, W, Smolle, K, Van Der Schueren, M, Thibo, P, Vanhoof, M, Ahmet, I, Philippe, G, Dufaye, P, Jacobs, O, Fraipont, V, Biston, P, Dive, A, Bouckaert, Y, Gilbert, E, Gressens, B, Pinck, E, Collin, V, De Waele, J, Rimachi, R, Gusu, D, De Decker, K, Mandianga, K, Heytens, L, Herbert, S, Olivier, V, Vandenheede, W, Rogiers, P, Kolodzeike, P, Kruse, M, Andersen, T, Harjola, V, Saarinen, K, Leone, M, Durocher, A, Moulront, S, Lepape, A, Losser, M, Cabaret, P, Kalaitzis, E, Zogheib, E, Charve, P, Francois, B, Beilouny, B, Forceville, X, Misset, B, Jacobs, F, Bernard, F, Payen, D, Wynckel, A, Castelain, V, Faure, A, Lavagne, P, Thierry, L, Moussa, M, Vieillard-Baron, A, Durand, M, Gainnier, M, Ichai, C, Arens, S, Hoffmann, C, Kaffarnik, M, Scharnofske, C, Voigt, I, Peckelsen, C, Weber, M, Gille, J, Lange, A, Schoser, G, Sablotzki, A, Jaschinski, U, Bluethgen, A, Vogel, F, Tscheu, A, Fuchs, T, Wattenberg, M, Helmes, T, Scieszka, S, Heintz, M, Kohler, J, Fiedler, F, Danz, M, Riessen, R, Kerz, T, Kersten, A, Tacke, F, Marx, G, Volkert, T, Schmutz, A, Nierhaus, A, Kluge, S, Abel, P, Janosi, R, Utzolino, S, Bracht, H, Toussaint, S, Giannakou Peftoulidou, M, Myrianthefs, P, Armaganidis, A, Routsi, C, Xini, A, Mouloudi, E, Kokoris, I, Kyriazopoulos, G, Vlachos, S, Lavrentieva, A, Partala, P, Nakos, G, Barry, J, O'Leary, R, Motherway, C, Faheem, M, Dunne, E, Donnelly, M, Konrad, T, Bonora, E, Achilli, C, Rossi, S, Castiglione, G, Peris, A, Albanese, D, Stocchetti, N, Citerio, G, Mozzoni, L, Sisillo, E, De Negri, P, Savioli, M, Vecchiarelli, P, Puflea, F, Stankovic, V, Minoja, G, Montibeller, S, Calligaro, P, Sorrentino, R, Feri, M, Zambon, M, Colombaroli, E, Giarratano, A, Pellis, T, Capra, C, Antonelli, M, Gullo, A, Chelazzi, C, De Capraris, A, Patroniti, N, Girardis, M, Franchi, F, Berlot, G, Ponssen, H, Ten Cate, J, Bormans, L, Husada, S, Buise, M, Van Der Hoven, B, Reidinga, A, Kuiper, M, Kluge, G, Den Boer, S, Kesecioglu, J, Van Leeuwen, H, Flaatten, H, Mo, S, Branco, V, Rua, F, Lafuente, E, Sousa, M, Catorze, N, Barros, M, Pereira, L, Vintem De Oliveira, A, Gomes, J, Gaspar, I, Pereira, M, Cymbron, M, Dias, A, Almeida, E, Beirao, S, Serra, I, Ribeiro, R, Povoa, P, Faria, F, Costa-E-Silva, Z, Nobrega, J, Fernandes, F, Gabriel, J, Voga, G, Rupnik, E, Kosec, L, Kerin Povsic, M, Osojnik, I, Tomic, V, Sinkovic, A, Gonzalez, J, Zavala, E, Perez Valenzuela, J, Marina, L, Vidal-Cortes, P, Posada, P, Ignacio Martin-Loeches, A, Munoz Guillen, N, Palomar, M, Sole-Violan, J, Torres, A, Gonzalez Gallego, M, Aguilar, G, Montoiro Allue, R, Argueso, M, Parejo, M, Palomo Navarro, M, Jose, A, Nin, N, Alvarez Lerma, F, Martinez, O, Tenza Lozano, E, Arenal Lopez, S, Perez Granda, M, Moreno, S, Llubia, C, De La Fuente Martos, C, Gonzalez-Arenas, P, Llamas Fernandez, N, Gil Rueda, B, Estruch Pons, I, Cruza, N, Maroto, F, Estella, A, Ferrer, A, Iglesias Fraile, L, Quindos, B, Quintano, A, Tebar, M, Cardinal, P, Reyes, A, Rodriguez, A, Abella, A, Garcia Del Valle, S, Yus, S, Maseda, E, Berezo, J, Tejero Pedregosa, A, Laplaza, C, Ferrer, R, Rico-Feijoo, J, Rodriguez, M, Monedero, P, Eriksson, K, Lind, D, Chabanel, D, Zender, H, Heer, K, Frankenberger, B, Jakob, S, Haller, A, Mathew, S, Downes, R, Barrera Groba, C, Johnston, A, Meacher, R, Keays, R, Haji-Michael, P, Tyler, C, Ferguson, A, Jones, S, Tyl, D, Ball, A, Vogel, J, Booth, M, Downie, P, Watters, M, Brett, S, Garfield, M, Everett, L, Heenen, S, Dhir, S, Beardow, Z, Mostert, M, Brosnan, S, Pinto, N, Harris, S, Summors, A, Andrew, N, Rose, A, Appelboam, R, Davies, O, Vickers, E, Agarwal, B, Szakmany, T, Wimbush, S, Welters, I, Pearse, R, Hollands, R, Kirk-Bayley, J, Fletcher, N, Bray, B, Brealey, D, Delle Karth, G, Draxler, V, Filzwieser, G, Heindl, W, Kellner, G, Lenz, K, Rossmann, E, Wiedermann, C, Chochrad, D, Damas, P, Decruyenaere, J, Hoste, E, Devriendt, J, Espeel, B, Installe, E, Malbrain, M, Nollet, G, Preiser, J, Raemaekers, J, Roman, A, Simon, M, Spapen, H, Swinnen, W, Vallot, F, Chytra, I, Herold, I, Polak, F, Sterba, M, Bestle, M, Espersen, K, Guldager, H, Welling, K, Nyman, D, Ruokonen, E, Annane, D, Catogni, P, Colas, G, Coulomb, F, Dorne, R, Garrouste, M, Isetta, C, Larche, J, Legall, J, Lessire, H, Malledant, Y, Mateu, P, Ossart, M, Schlossmacher, P, Timsit, J, Winnock, S, Sollet, J, Mallet, L, Maurer, P, Sab, J, Aykut, G, Brunkhorst, F, Lauterbach, M, Ragaller, M, Gatz, R, Gerlach, H, Henzler, D, Hopf, H, Hueneburg, H, Karzai, W, Keller, A, Bauer, T, Kuhlmann, U, Langgartner, J, Manhold, C, Reith, B, Schuerholz, T, Spies, C, Stogbauer, R, Unterburger, J, Clouva-Molyvdas, P, Giokas, G, Ioannidou, E, Lahana, A, Liolios, A, Marathias, K, Tasiou, A, Tsangaris, H, Marsh, B, Power, M, Sprung, C, Biagioli, B, Bobbio Pallavicini, F, Pesenti, A, Della Corte, F, Donadio, P, Donati, A, Giorgio, T, Giudici, D, Greco, S, Guadagnucci, A, Lapichino, G, Livigni, S, Moise, G, Nardi, G, Panascia, E, Pizzamiglio, M, Ranieri, V, Rosi, R, Sicignano, A, Solca, M, Vignali, G, Volpe Rinonapoli, I, Barnas, M, De Bel, E, De Pont, A, Groeneveld, J, Nijsten, M, Sie, L, Zandstra, D, Harboe, S, Linden, S, Lovstad, R, Moen, H, Smith-Erichsen, N, Piotrowski, A, Karpel, E, Pais-De-Lacerda, A, Paiva, J, Pimentel, A, Jovanovic, K, Malik, P, Lucka, K, Aldecoa Alvarez-Santullano, C, Artigas, A, Escorsell, A, Nicolas, J, Izura Cea, J, Montejo, J, Palencia, E, Santos, F, Sierra-Camerino, R, Sipmann, F, Brodersen, K, Haggqvist, J, Hermansson, D, Hjelmqvist, H, Loderer, G, Maggiorini, M, Andrews, P, Appadu, B, Bewley, J, Burchett, K, Chambers, P, Coakley, J, Doberenz, D, Eastwood, N, Fielden, J, Gedney, J, Gunning, K, Harling, D, Jankowski, S, Jayson, D, Kilner, A, Krishna-Kumar, V, Lei, K, Mackenzie, S, Macnaughton, P, Mcculloch, C, Morgan, P, Rhodes, A, Roberts, C, Russell, M, Tupper-Carey, D, Wright, M, Twohey, L, Watts, J, Webster, R, Williams, D, Vincent J. -L., Lefrant J. -Y., Kotfis K., Nanchal R., Martin-Loeches I., Wittebole X., Sakka S. G., Pickkers P., Moreno R., Sakr Y., Pavlik P., Manak J., Kieslichova E., Turek R., Fischer M., Valkova R., Dadak L., Dostal P., Malaska J., Hajek R., Zidkova A., Lavicka P., Medve L., Sarkany A., Kremer I., Marjanek Z., Tamasi P., Kolbusz J., Kubler A., Mielczarek B., Mikaszewska-Sokolewicz M., Tamowicz B., Sulkowski W., Smuszkiewicz P., Pihowicz A., Trejnowska E., Hagau N., Filipescu D., Droc G., Lupu M., Nica A., Stoica R., Tomescu D., Constantinescu D., Valcoreanu Zbaganu G., Slavcovici A., Soskic L., Palibrk I., Jankovic R., Jovanovic B., Pandurovic M., Bumbasirevic V., Uljarevic B., Surbatovic M., Ladjevic N., Slobodianiuk G., Sobona V., Cikova A., Gebhardtova A., Cohen J., Sold O., Urbanek P., Schlieber J., Reisinger J., Auer J., Hartjes A., Lerche A., Janous T., Kink E., Krahulec W., Smolle K., Van Der Schueren M., Thibo P., Vanhoof M., Ahmet I., Philippe G., Dufaye P., Jacobs O., Fraipont V., Biston P., Dive A., Bouckaert Y., Gilbert E., Gressens B., Pinck E., Collin V., De Waele J., Rimachi R., Gusu D., De Decker K., Mandianga K., Heytens L., Herbert S., Olivier V., Vandenheede W., Rogiers P., Kolodzeike P., Kruse M., Andersen T., Harjola V., Saarinen K., Leone M., Durocher A., Moulront S., Lepape A., Losser M., Cabaret P., Kalaitzis E., Zogheib E., Charve P., Francois B., Beilouny B., Forceville X., Misset B., Jacobs F., Bernard F., Payen D., Wynckel A., Castelain V., Faure A., Lavagne P., Thierry L., Moussa M., Vieillard-Baron A., Durand M., Gainnier M., Ichai C., Arens S., Hoffmann C., Kaffarnik M., Scharnofske C., Voigt I., Peckelsen C., Weber M., Gille J., Lange A., Schoser G., Sablotzki A., Jaschinski U., Bluethgen A., Vogel F., Tscheu A., Fuchs T., Wattenberg M., Helmes T., Scieszka S., Heintz M., Sakka S., Kohler J., Fiedler F., Danz M., Riessen R., Kerz T., Kersten A., Tacke F., Marx G., Volkert T., Schmutz A., Nierhaus A., Kluge S., Abel P., Janosi R., Utzolino S., Bracht H., Toussaint S., Giannakou Peftoulidou M., Myrianthefs P., Armaganidis A., Routsi C., Xini A., Mouloudi E., Kokoris I., Kyriazopoulos G., Vlachos S., Lavrentieva A., Partala P., Nakos G., Barry J., O'Leary R., Motherway C., Faheem M., Dunne E., Donnelly M., Konrad T., Bonora E., Achilli C., Rossi S., Castiglione G., Peris A., Albanese D., Stocchetti N., Citerio G., Mozzoni L., Sisillo E., De Negri P., Savioli M., Vecchiarelli P., Puflea F., Stankovic V., Minoja G., Montibeller S., Calligaro P., Sorrentino R., Feri M., Zambon M., Colombaroli E., Giarratano A., Pellis T., Capra C., Antonelli M., Gullo A., Chelazzi C., De Capraris A., Patroniti N., Girardis M., Franchi F., Berlot G., Ponssen H., Ten Cate J., Bormans L., Husada S., Buise M., Van Der Hoven B., Reidinga A., Kuiper M., Kluge G., Den Boer S., Kesecioglu J., Van Leeuwen H., Flaatten H., Mo S., Branco V., Rua F., Lafuente E., Sousa M., Catorze N., Barros M., Pereira L., Vintem De Oliveira A., Gomes J., Gaspar I., Pereira M., Cymbron M., Dias A., Almeida E., Beirao S., Serra I., Ribeiro R., Povoa P., Faria F., Costa-E-Silva Z., Nobrega J., Fernandes F., Gabriel J., Voga G., Rupnik E., Kosec L., Kerin Povsic M., Osojnik I., Tomic V., Sinkovic A., Gonzalez J., Zavala E., Perez Valenzuela J., Marina L., Vidal-Cortes P., Posada P., Ignacio Martin-Loeches A., Munoz Guillen N., Palomar M., Sole-Violan J., Torres A., Gonzalez Gallego M., Aguilar G., Montoiro Allue R., Argueso M., Parejo M., Palomo Navarro M., Jose A., Nin N., Alvarez Lerma F., Martinez O., Tenza Lozano E., Arenal Lopez S., Perez Granda M., Moreno S., Llubia C., De La Fuente Martos C., Gonzalez-Arenas P., Llamas Fernandez N., Gil Rueda B., Estruch Pons I., Cruza N., Maroto F., Estella A., Ferrer A., Iglesias Fraile L., Quindos B., Quintano A., Tebar M., Cardinal P., Reyes A., Rodriguez A., Abella A., Garcia Del Valle S., Yus S., Maseda E., Berezo J., Tejero Pedregosa A., Laplaza C., Ferrer R., Rico-Feijoo J., Rodriguez M., Monedero P., Eriksson K., Lind D., Chabanel D., Zender H., Heer K., Frankenberger B., Jakob S., Haller A., Mathew S., Downes R., Barrera Groba C., Johnston A., Meacher R., Keays R., Haji-Michael P., Tyler C., Ferguson A., Jones S., Tyl D., Ball A., Vogel J., Booth M., Downie P., Watters M., Brett S., Garfield M., Everett L., Heenen S., Dhir S., Beardow Z., Mostert M., Brosnan S., Pinto N., Harris S., Summors A., Andrew N., Rose A., Appelboam R., Davies O., Vickers E., Agarwal B., Szakmany T., Wimbush S., Welters I., Pearse R., Hollands R., Kirk-Bayley J., Fletcher N., Bray B., Brealey D., Delle Karth G., Draxler V., Filzwieser G., Heindl W., Kellner G., Lenz K., Rossmann E., Wiedermann C., Chochrad D., Damas P., Decruyenaere J., Hoste E., Devriendt J., Espeel B., Installe E., Malbrain M., Nollet G., Preiser J. C., Raemaekers J., Roman A., Simon M., Spapen H., Swinnen W., Vallot F., Chytra I., Herold I., Polak F., Sterba M., Bestle M., Espersen K., Guldager H., Welling K. -L., Nyman D., Ruokonen E., Annane D., Catogni P., Colas G., Coulomb F., Dorne R., Garrouste M., Isetta C., Larche J., LeGall J. -R., Lessire H., Malledant Y., Mateu P., Ossart M., Schlossmacher P., Timsit J. -F., Winnock S., Sollet J. -P., Mallet L., Maurer P., Sab J. M., Aykut G., Brunkhorst F., Lauterbach M., Ragaller M., Gatz R., Gerlach H., Henzler D., Hopf H. -B., Hueneburg H., Karzai W., Keller A., Bauer T., Kuhlmann U., Langgartner J., Manhold C., Reith B., Schuerholz T., Spies C., Stogbauer R., Unterburger J., Clouva-Molyvdas P. -M., Giokas G., Ioannidou E., Lahana A., Liolios A., Marathias K., Tasiou A., Tsangaris H., Marsh B., Power M., Sprung C., Biagioli B., Bobbio Pallavicini F., Pesenti A., Della Corte F., Donadio P. P., Donati A., Giorgio T., Giudici D., Greco S., Guadagnucci A., Lapichino G., Livigni S., Moise G., Nardi G., Panascia E., Pizzamiglio M., Ranieri V. M., Rosi R., Sicignano A., Solca M., Vignali G., Volpe Rinonapoli I., Barnas M., De Bel E. E., De Pont A. -C., Groeneveld J., Nijsten M., Sie L., Zandstra D. F., Harboe S., Linden S., Lovstad R. Z., Moen H., Smith-Erichsen N., Piotrowski A., Karpel E., Pais-De-Lacerda A., Paiva J. A., Pimentel A., Jovanovic K., Malik P., Lucka K., Aldecoa Alvarez-Santullano C., Artigas A., Escorsell A., Nicolas J., Izura Cea J. J., Montejo J., Palencia E., Santos F., Sierra-Camerino R., Sipmann F., Brodersen K., Haggqvist J., Hermansson D., Hjelmqvist H., Loderer G., Maggiorini M., Andrews P., Appadu B., Bewley J., Burchett K., Chambers P., Coakley J., Doberenz D., Eastwood N., Fielden J., Gedney J., Gunning K., Harling D., Jankowski S., Jayson D., Kilner A., Krishna-Kumar V., Lei K., Mackenzie S., Macnaughton P., McCulloch C., Morgan P., Rhodes A., Roberts C., Russell M., Tupper-Carey D., Wright M., Twohey L., Watts J., Webster R., and Williams D.
- Abstract
Purpose: To evaluate differences in the characteristics and outcomes of intensive care unit (ICU) patients over time. Methods: We reviewed all epidemiological data, including comorbidities, types and severity of organ failure, interventions, lengths of stay and outcome, for patients from the Sepsis Occurrence in Acutely ill Patients (SOAP) study, an observational study conducted in European intensive care units in 2002, and the Intensive Care Over Nations (ICON) audit, a survey of intensive care unit patients conducted in 2012. Results: We compared the 3147 patients from the SOAP study with the 4852 patients from the ICON audit admitted to intensive care units in the same countries as those in the SOAP study. The ICON patients were older (62.5 ± 17.0 vs. 60.6 ± 17.4 years) and had higher severity scores than the SOAP patients. The proportion of patients with sepsis at any time during the intensive care unit stay was slightly higher in the ICON study (31.9 vs. 29.6%, p = 0.03). In multilevel analysis, the adjusted odds of ICU mortality were significantly lower for ICON patients than for SOAP patients, particularly in patients with sepsis [OR 0.45 (0.35–0.59), p < 0.001]. Conclusions: Over the 10-year period between 2002 and 2012, the proportion of patients with sepsis admitted to European ICUs remained relatively stable, but the severity of disease increased. In multilevel analysis, the odds of ICU mortality were lower in our 2012 cohort compared to our 2002 cohort, particularly in patients with sepsis.
- Published
- 2018
232. How can personality influence perception on security of context-aware applications?
- Author
-
Condori-Fernandez, N., Suni-Lopez, F., Muñante, D., Daneva, M., Groß, Thomas, Viganò, Luca, Universidade da Coruña, Vrije Universiteit Amsterdam [Amsterdam] (VU), Universidad Nacional de San Agustín (UNSA), Institut Polytechnique de Paris (IP Paris), Département Informatique (INF), Institut Mines-Télécom [Paris] (IMT)-Télécom SudParis (TSP), Algorithmes, Composants, Modèles Et Services pour l'informatique répartie (ACMES-SAMOVAR), Services répartis, Architectures, MOdélisation, Validation, Administration des Réseaux (SAMOVAR), Institut Mines-Télécom [Paris] (IMT)-Télécom SudParis (TSP)-Institut Mines-Télécom [Paris] (IMT)-Télécom SudParis (TSP), University of Twente [Netherlands], Software and Sustainability (S2), Network Institute, Software & Services, Groß, Thomas, and Viganò, Luca
- Subjects
Agreeableness ,media_common.quotation_subject ,Context (language use) ,02 engineering and technology ,[INFO.INFO-SE]Computer Science [cs]/Software Engineering [cs.SE] ,Personality test ,[INFO.INFO-CR]Computer Science [cs]/Cryptography and Security [cs.CR] ,Perception ,0202 electrical engineering, electronic engineering, information engineering ,Personality ,0501 psychology and cognitive sciences ,Confidentiality ,Quality (business) ,Context aware applications ,Users perception ,Big Five personality traits ,Survey ,050107 human factors ,media_common ,05 social sciences ,020207 software engineering ,[INFO.INFO-MO]Computer Science [cs]/Modeling and Simulation ,Security ,Psychology ,Social psychology - Abstract
International audience; [Context and Motivation] Our lives are being transformed by context-aware software applications with important social, environmental, and economic implications. [Question/Problem] Experts recognized that quality attributes, e.g. security, are the cornerstone to get healthy social implications of these applications. However, do end-users (service consumers) perceive these attributes as so important? [Methodology] To answer this question, we designed a survey, to understand how end-users perceive security of context-aware software applications and how the users’ personality traits might influence their perceptions. To this end, we did a web-based survey that embeds two animated-demonstration videos in order to present i) the functionality of a context-aware mobile app, and ii) some vulnerabilities of the mobile app. It involved 48 subjects divided in two groups: subjects with software engineering (SE) background (Group A) and subjects without any SE background (Group B). [Results] Our study found that the importance of confidentiality and integrity is more clearly perceived by subjects with SE backgrounds (Group A). Accountability is more difficult to be perceived by subjects. And this difficulty can be even more pronounced for subjects without any SE background (Group B). Our findings suggest that importance preferences on security are influenced by personality types. For instance, open-minded people have a higher propensity to perceive the importance of confidentiality and integrity. Whilst, people with a high level of agreeableness hold quite different perceptions regarding the importance of authenticity and accountability. Analyzing the level of association between personality and the perceived importance on security, we found that the importance perceptions on confidentiality are influenced by the personality of subjects from Group B. And, the changes (positive an negative) in the importance perception on confidentiality are very strongly influenced by personality, even more so by the personality of subjects from Group B.
- Published
- 2020
233. Reinterpretation of LHC results for new physics: Status and recommendations after run 2
- Author
-
Abdallah, W, AbdusSalam, S, Ahmadov, A, Ahriche, A, Alguero, G, Allanach, BC, Araz, JY, Arbey, A, Arina, C, Athron, P, Bagnaschi, E, Bai, Y, Baker, MJ, Balazs, C, Barducci, D, Bechtle, P, Bharucha, A, Buckley, A, Butterworth, J, Cai, H, Campagnari, C, Cesarotti, C, Chrzaszcz, M, Coccaro, A, Conte, E, Cornell, JM, Corpe, LD, Danninger, M, Darmé, L, Deandrea, A, Desai, N, Dillon, B, Doglioni, C, Dolan, MJ, Dutta, J, Ellis, JR, Ellis, S, Feickert, M, Fernandez, N, Fichet, S, Flacke, T, Fuks, B, Geiser, A, Genest, MH, Ghalsasi, A, Gonzalo, T, Goodsell, M, Gori, S, Gras, P, Greljo, A, Guadagnoli, D, Heinemeyer, S, Heinrich, LA, Heisig, J, Hong, DK, Hryn'ova, T, Huitu, K, Ilten, P, Ismail, A, Jueid, A, Kahlhoefer, F, Kalinowski, J, Kamenik, JF, Kar, D, Kats, Y, Khosa, CK, Khoze, V, Klingl, T, Ko, P, Kong, K, Kotlarski, W, Krämer, M, Kraml, S, Kulkarni, S, Kvellestad, A, Lange, C, Lassila-Perini, K, Lee, SJ, Lessa, A, Liu, Z, Iglesias, LL, Lorenz, JM, MacDonell, D, Mahmoudi, F, Mamuzic, J, Marini, AC, Markowitz, P, del Arbol, PMR, Miller, D, Mitsou, VA, Moretti, S, Nardecchia, M, Neshatpour, S, Nhung, DT, Osland, P, Owen, PH, Panella, O, Pankov, A, Park, M, Porod, W, Allanach, Benjamin [0000-0003-4635-6830], and Apollo - University of Cambridge Repository
- Subjects
hep-ex ,hep-ph - Abstract
We report on the status of efforts to improve the reinterpretation of searches and measurements at the LHC in terms of models for new physics, in the context of the LHC Reinterpretation Forum. We detail current experimental offerings in direct searches for new particles, measurements, technical implementations and Open Data, and provide a set of recommendations for further improving the presentation of LHC results in order to better enable reinterpretation in the future. We also provide a brief description of existing software reinterpretation frameworks and recent global analyses of new physics that make use of the current data.
- Published
- 2020
- Full Text
- View/download PDF
234. Repercusión clínica del patrón temporal de las sacadas de refijación: caracterización, origen y significado
- Author
-
Guajardo-Vergara, C. (Carlos) and Perez-Fernandez, N. (Nicolás)
- Subjects
Ciencias de la Salud::Otorrinolaringología [Materias Investigacion] - Abstract
En sujetos que presentan un déficit vestibular no compensado, secuela de una vestibulopatía aguda unilateral, la sincronización de la respuesta ocular refijadora es un marcador del grado de compensación vestibular logrado.Los objetivos de esta tesis son: a) Establecer las diferencias que se encuentran entre el estado de compensación vestibular y el patrón temporal de las sacadas de refijación en el déficit vestibular agudo unilateral. b) Desarrollar y proponer un nuevo método de evaluación objetiva de la compensación vestibular. c) Determinar el tipo de sacadas de refijación más frecuentes y caracterizarlas de acuerdo al grado de organización de la respuesta que presentan sujetos con déficit vestibular agudo unilateral.
- Published
- 2020
235. Wrist traction interferes with the arthroscopic evaluation and surgical repair of the scapholunate misalignement. A kinetic study in cadavers
- Author
-
Esplugas, M, Lluch-Bergada, A, Garcia-Elias, M, Añaños, D, Salva-Coll, G, Rodriguez-Baeza, A, Fernandez, N, and Puig De La Bellacasa, I
- Subjects
body regions ,arthroscopy traction ,ddc: 610 ,scapholunate arthroscopic repair ,610 Medical sciences ,Medicine ,musculoskeletal system ,unstable scapholunate joint - Abstract
Objectives/Interrogation: Axial loading of a wrist with deficient scapholunate ligament (SLL) induces scaphoid flexion and pronation, the radioscaphoid peak pressure displacing dorsoradially. This study was designed to document the alignment of the scaphoid and the lunate under axial traction[for full text, please go to the a.m. URL], 14th Triennial Congress of the International Federation of Societies for Surgery of the Hand (IFSSH), 11th Triennial Congress of the International Federation of Societies for Hand Therapy (IFSHT), 11th Triennial Congress of the International Federation of Societies for Hand Therapy (IFSHT)
- Published
- 2020
- Full Text
- View/download PDF
236. Postoperative immobilization in forearm pronation protects any scapholunate surgical repair. A kinetic study in cadavers
- Author
-
Esplugas, M, Salva-Coll, G, Garcia-Elias, M, Lluch-Bergada, A, Puig De La Bellacasa, I, Fernandez, N, and Llusá-Pérez, M
- Subjects
body regions ,ddc: 610 ,scapholunate ligament surgical repair postoperative protection ,scapholunate instability ,610 Medical sciences ,Medicine - Abstract
Objectives/Interrogation: To analyze: if there are significant changes in the alignment of the unstable scaphoid relative to the rest of the proximal carpal row alignment during forearm rotations and if there is one forearm rotation that best reduces scapholunate misalignment. Methods:[for full text, please go to the a.m. URL], 14th Triennial Congress of the International Federation of Societies for Surgery of the Hand (IFSSH), 11th Triennial Congress of the International Federation of Societies for Hand Therapy (IFSHT), 11th Triennial Congress of the International Federation of Societies for Hand Therapy (IFSHT)
- Published
- 2020
- Full Text
- View/download PDF
237. Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy forHelicobacter pyloriinfection: Spanish data of the EuropeanHelicobacter pyloriRegistry (Hp-EuReg)
- Author
-
Nyssen, OP, Perez-Aisa, A, Rodrigo, L, Castro, M, Romero, PM, Ortu?o, J, Barrio, J, Huguet, JM, Modollel, I, Alcaide, N, Lucendo, A, Calvet, X, Perona, M, Gomez, B, Rodriguez, BJG, Varela, P, Jimenez-Moreno, M, Dominguez-Cajal, M, Pozzati, L, Burgos, D, Bujanda, L, Hinojosa, J, Molina-Infante, J, Di Maira, T, Ferrer, L, Fern?ndez-Salazar, L, Figuerola, A, Tito, L, de la Coba, C, Gomez-Camarero, J, Fernandez, N, Caldas, M, Garre, A, Resina, E, Puig, I, O'Morain, C, Megraud, F, and Gisbert, JP
- Subjects
metronidazole ,doxycycline ,Helicobacter pylori ,bismuth ,polycyclic compounds ,Pylera(R) ,tetracycline - Abstract
Background Different bismuth quadruple therapies containing proton-pump inhibitors, bismuth salts, metronidazole, and a tetracycline have been recommended as third-lineHelicobacter pylorieradication treatment after failure with clarithromycin and levofloxacin. Aim To evaluate the efficacy and safety of third-line treatments with bismuth, metronidazole, and either tetracycline or doxycycline. Methods Sub-study with Spanish data of the "European Registry onH pyloriManagement" (Hp-EuReg), international multicenter prospective non-interventional Registry of the routine clinical practice of gastroenterologists. After previous failure with clarithromycin- and levofloxacin-containing therapies, patients receiving a third-line regimen with 10/14-day bismuth salts, metronidazole, and either tetracycline (BQT-Tet) or doxycycline (BQT-Dox), or single capsule (BQT-three-in-one) were included. Data were registered at AEG-REDCap database. Univariate and multivariate analyses were performed. Results Four-hundred and fifty-four patients have been treated so far: 85 with BQT-Tet, 94 with BQT-Dox, and 275 with BQT-three-in-one. Average age was 53 years, 68% were women. Overall modified intention-to-treat and per-protocol eradication rates were 81% (BQT-Dox: 65%, BQT-Tet: 76%, BQT-three-in-one: 88%) and 82% (BQT-Dox: 66%, BQT-Tet: 77%, BQT-three-in-one: 88%), respectively. By logistic regression, higher eradication rates were associated with compliance (OR = 2.96; 95% CI = 1.01-8.84) and no prior metronidazole use (OR = 1.96; 95% CI = 1.15-3.33); BQT-three-in-one was superior to BQT-Dox (OR = 4.46; 95% CI = 2.51-8.27), and BQT-Tet was marginally superior to BQT-Dox (OR = 1.67; 95% CI = 0.85-3.29). Conclusion Third-lineH pylorieradication with bismuth quadruple treatment (after failure with clarithromycin and levofloxacin) offers acceptable efficacy and safety. Highest efficacy was found in compliant patients and those taking 10-day BQT-three-in-one or 14-day BQT-Tet. Doxycycline seems to be less effective and therefore should not be recommended.
- Published
- 2020
238. Breakthrough cancer pain: review and calls to action to improve its management
- Author
-
Camps Herrero C, Batista N, Diaz Fernandez N, Escobar Alvarez Y, Gonzalo Gomez A, Isla Casado D, Salud A, Terrasa Pons J, and Guillem Porta V
- Subjects
Approach ,Breakthrough cancer pain ,Barriers ,Actions - Abstract
In this paper, we review the current state of breakthrough cancer pain (BTcP) management. BTcP is a heterogeneous condition and a global problem for cancer patients. It is often managed suboptimally, which results in a negative outcome for patients, healthcare providers, and healthcare systems. Several barriers to the appropriate management of BTcP have been identified. These include, among others, an incomplete definition of BTcP, poor training of healthcare providers and patients alike, a lack of a multidisciplinary approach and the absence of specific protocols and tools. We provide some actions to help physicians and patients improve their approach to BTcP, including specific training, the design of easy-to-use tools for BTcP identification and assessment (such as checklists and pocket-sized cards), individualized treatment, and the use of multidisciplinary teams.
- Published
- 2020
239. Variants of the Aggression-Related RBFOX1 Gene in a Population Representative Birth Cohort Study: Aggressiveness, Personality, and Alcohol Use Disorder
- Author
-
Vaht M, Laas K, Fernandez N, Kurrikoff T, Kanarik M, Faraone SV, Tooding LM, Veidebaum T, Franke B, Reif A, Cormand B, and Harro J
- Subjects
A2BP1 ,extraversion ,gender ,neuroticism ,aggressiveness ,alcohol use disorder ,RBFOX1 - Abstract
Background: Recently, RBFOX1, a gene encoding an RNA binding protein, has consistently been associated with aggressive and antisocial behavior. Several loci in the gene have been nominally associated with aggression in genome-wide association studies, the risk alleles being more frequent in the general population. We have hence examined the association of four RBFOX1 single nucleotide polymorphisms, previously found related to aggressive traits, with aggressiveness, personality, and alcohol use disorder in birth cohort representative samples. Methods: We used both birth cohorts of the Estonian Children Personality Behavior and Health Study (ECPBHS; original n = 1,238). Aggressiveness was assessed using the Buss-Perry Aggression Questionnaire and the Lifetime History of Aggressiveness structured interview at age 25 (younger cohort) or 33 (older cohort). Big Five personality at age 25 was measured with self-reports and the lifetime occurrence of alcohol use disorder assessed with the MINI interview. RBFOX1 polymorphisms rs809682, rs8062784, rs12921846, and rs6500744 were genotyped in all participants. Given the restricted size of the sample, correction for multiple comparisons was not applied. Results: Aggressiveness was not significantly associated with the RBFOX1 genotype. RBFOX1 rs8062784 was associated with neuroticism and rs809682 with extraversion. Two out of four analyzed RBFOX1 variants, rs8062784 and rs12921846, were associated with the occurrence of alcohol use disorder. Conclusions: In the birth cohort representative sample of the ECPBHS, no association of RBFOX1 with aggressiveness was found, but RBFOX1 variants affected basic personality traits and the prevalence of alcohol use disorder. Future studies on RBFOX1 should consider the moderating role of personality and alcohol use patterns in aggressiveness.
- Published
- 2020
240. Massive Hemothorax Due to Intrathoracic Herniation of the Gastric Remnant After Roux-en-Y Gastric Bypass with Concurrent Hiatal Hernia Repair (vol 46, pg 513, 2020)
- Author
-
Oliver I, Ballester R, Fischer G, Riesco A, Fernandez N, and Serrano J
- Published
- 2020
241. Corrigendum to 'Evaluation of previous substance dependence genome-wide significant findings in a Spanish sample' [Drug Alcohol Depend. 187 (2018) 358-362]
- Author
-
Pineda L, Cabana J, Roncero C, Cozar M, Grau-López L, Abad AC, Martínez-Luna N, Robles-Martínez M, Sánchez-Mora C, Ramos-Quiroga JA, Casas M, Ribasés M, Fernandez N, and Cormand B
- Published
- 2020
242. Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg)
- Author
-
Nyssen, O. P., Perez-Aisa, A., Tepes, B., Rodrigo-Saez, L., Romero, P. M., Lucendo, A., Castro-Fernandez, M., Phull, P., Barrio, J., Bujanda, L., Ortuno, J., Areia, M., Brglez Jurecic, N., Huguet, J. M., Alcaide, N., Voynovan, I., Maria Botargues Bote, J., Modolell, I., Perez Lasala, J., Arino, I., Jonaitis, L., Dominguez-Cajal, M., Buzas, G., Lerang, F., Perona, M., Bordin, D., Axon, T., Gasbarrini, Antonio, Marcos Pinto, R., Niv, Y., Kupcinskas, L., Tonkic, A., Leja, M., Rokkas, T., Boyanova, L., Shvets, O., Venerito, M., Bytzer, P., Goldis, A., Simsek, I., Lamy, V., Przytulski, K., Kunovsky, L., Capelle, L., Milosavljevic, T., Caldas, M., Garre, A., Megraud, F., O'Morain, C., Gisbert, J. P., Hinojosa, J., Fernandez, N., Molina Infante, J., Alonso Galan, H., Di Maira, T., Alves, S. I., Saraiva, S., Elvas, L., Brito, D., Teresa Cadime, A., Lampic, P., Gruncic, A., Leban, V., Ferrer, L., Fernandez Salazar, L., Lanas, A., Kristensen, V., Brackmann, S., Delchier, J. C., Anton, C., Gomez Rodriguez, B. J., Pellicano, R., Boltin, D., and Gastroenterology & Hepatology
- Subjects
medicine.medical_specialty ,Allergy ,Settore MED/12 - GASTROENTEROLOGIA ,allergic ,Penicillins ,Gastroenterology ,Helicobacter Infections ,Drug Hypersensitivity ,03 medical and health sciences ,0302 clinical medicine ,Levofloxacin ,Metronidazole ,Clarithromycin ,Internal medicine ,bismuth ,medicine ,Humans ,Prospective Studies ,Registries ,Adverse effect ,levofloxacin ,biology ,Helicobacter pylori ,business.industry ,Settore MED/09 - MEDICINA INTERNA ,allergy ,clarithromycin ,penicillin ,Proton Pump Inhibitors ,General Medicine ,Tetracycline ,biology.organism_classification ,medicine.disease ,Anti-Bacterial Agents ,3. Good health ,Penicillin ,Regimen ,Infectious Diseases ,030220 oncology & carcinogenesis ,Drug Therapy, Combination ,030211 gastroenterology & hepatology ,business ,medicine.drug - Abstract
Background Experience in Helicobacter pylori eradication treatment of patients allergic to penicillin is very scarce. A triple combination with a PPI, clarithromycin (C), and metronidazole (M) is often prescribed as the first option, although more recently the use of a quadruple therapy with PPI, bismuth (B), tetracycline (T), and M has been recommended. Aim To evaluate the efficacy and safety of first-line and rescue treatments in patients allergic to penicillin in the "European Registry of H pylori management" (Hp-EuReg). Methods A systematic prospective registry of the clinical practice of European gastroenterologists (27 countries, 300 investigators) on the management of H pylori infection. An e-CRF was created on AEG-REDCap. Patients with penicillin allergy were analyzed until June 2019. Results One-thousand eighty-four patients allergic to penicillin were analyzed. The most frequently prescribed first-line treatments were as follows: PPI + C + M (n = 285) and PPI + B + T + M (classic or Pylera(R); n = 250). In first line, the efficacy of PPI + C + M was 69%, while PPI + B + T + M reached 91% (P < .001). In second line, after the failure of PPI + C + M, two rescue options showed similar efficacy: PPI + B + T + M (78%) and PPI + C + levofloxacin (L) (71%) (P > .05). In third line, after the failure of PPI + C + M and PPI + C + L, PPI + B + T + M was successful in 75% of cases. Conclusion In patients allergic to penicillin, a triple combination with PPI + C + M should not be generally recommended as a first-line treatment, while a quadruple regimen with PPI + B + T + M seems to be a better option. As a rescue treatment, this quadruple regimen (if not previously prescribed) or a triple regimen with PPI + C + L could be used but achieved suboptimal (
- Published
- 2020
243. RBFOX1, encoding a splicing regulator, is a candidate gene for aggressive behavior
- Author
-
Fernandez N, Gan G, van Donkelaar MMJ, Vaht M, Weber H, Retz W, Meyer-Lindenberg A, Franke B, Harro J, Reif A, Faraone SV, and Cormand B
- Subjects
Epigenetics ,Neuroimaging ,Aggression ,RBFOX1 ,Animal models ,Genetics, Transcriptomics ,A2BP1 - Abstract
The RBFOX1 gene (or A2BP1) encodes a splicing factor important for neuronal development that has been related to autism spectrum disorder and other neurodevelopmental phenotypes. Evidence from complementary sources suggests that this gene contributes to aggressive behavior. Suggestive associations with RBFOX1 have been identified in genome-wide association studies (GWAS) of anger, conduct disorder, and aggressive behavior. Nominal association signals in RBFOX1 were also found in an epigenome-wide association study (EWAS) of aggressive behavior. Also, variants in this gene affect temporal lobe volume, a brain area that is altered in several aggression-related phenotypes. In animals, this gene has been shown to modulate aggressive behavior in Drosophila. RBFOX1 has also been associated with canine aggression and is upregulated in mice that show increased aggression after frustration of an expected reward. Associated common genetic variants as well as rare duplications and deletions affecting RBFOX1 have been identified in several psychiatric and neurodevelopmental disorders that are often comorbid with aggressive behaviors. In this paper, we comprehensively review the cumulative evidence linking RBFOX1 to aggression behavior and provide new results implicating RBFOX1 in this phenotype. Most of these studies (genetic and epigenetic analyses in humans, neuroimaging genetics, gene expression and animal models) are hypothesis-free, which strengthens the validity of the findings, although all the evidence is nominal and should therefore be taken with caution. Further studies are required to clarify in detail the role of this gene in this complex phenotype.
- Published
- 2020
244. Soil Moisture Product Validation Good Practices Protocol Version 1.0
- Author
-
Montzka, Carsten, Cosh, M., Chan, S., Colliander, A., Crow, W., Das, N., De Lannoy, G., Dorigo, W., Evett, S. R., Gruber, A., Hahn, S., Jagdhuber, T., Bayat, B., Jones, S., Kerr, Y., Kim, S., Koyama, C., Kurum, M., Lopez-Baeza, E., Mattia, F., McColl, K., Mecklenburg, S., Mohanty, B., Al Bitar, A., O´Neill, P., Or, D., Pellarin, T., Petropoulos, G. P., Piles, M., Reichle, R. H., Rodriguez-Fernandez, N., Rüdiger, C., Scanlon, T., Schwartz, R. C., Berg, A., Spengler, D., Srivastava, P., Suman, S., van der Schalie, R., Wagner, W., Wegmüller, U., Wigneron, J.-P., Camacho, F., Nickeson, J., Bindlish, R., Bogena, Heye, Bolten, J. D., Cabot, F., and Caldwell, T.
- Published
- 2020
245. Analysis of mid-term weight loss after Roux-en-Y gastric bypass and sleeve gastrectomy: Proposed percentile charts for total weight loss percentages to be used in daily clinical practice
- Author
-
Pereferrer F, Lopez A, Gandara D, Martin J, Boileve J, Moreno A, Fernandez N, Dejardin D, Alsina E, Ferrer-Marquez M, Muntwyler E, Garcia-Almenta E, and de Gordejuela A
- Subjects
Roux-en-Y gastric bypass ,%TWL ,Percentile charts ,Sleeve gastrectomy - Abstract
Introduction: The aim of this study is to analyze weight evolution after the main bariatric surgical techniques (Roux-en-Y gastric bypass [RYGB] and sleeve gastrectomy [SG]) performed at a representative sample of Spanish hospitals in order to develop percentile charts for the percentage of total weight loss during the first 3 years after surgery. Methods: A retrospective longitudinal cohort study was conducted based on the data provided by 9 Spanish hospitals. Weight data were analyzed both in % total weight loss and % excess weight lost corresponding to the RYGB (n = 1,887) and SG (n = 1,210). Results: RYGB continues to be the most frequently performed technique in our sample. In both surgical techniques, maximum weight loss occurred 18 months after surgery. Both techniques followed the same weight evolution, although the % total weight loss values were lower in the case of the SG after 36 months (29.3 +/- 10 vs. 33.6 +/- 10). Age and gender are decisive in the weight results (better in younger patients for both techniques and better in women for RYGB). Conclusions: Percentile charts of % total weight loss after bariatric surgery represent a very useful tool and an important advance in the quality of patient management. (C) 2019 AEC. Published by Elsevier Espana, S.L.U. All rights reserved.
- Published
- 2020
246. DDC expression is not regulated by NFAT5 (TonEBP) in dopaminergic neural cell lines
- Author
-
Pineda L, Cabana J, Beneto N, Diez H, Arenas C, Cormand B, and Fernandez N
- Subjects
integumentary system ,AADC, DDC, Hypertonic stress, NFAT5, Neural dopaminergic cell lines, PC12, SH-SY5Y, TonEBP - Abstract
The nuclear factor of activated T-cells 5 (NFAT5), also known as tonicity-responsive enhancer-binding protein (TonEBP), is a transcription factor that regulates osmoadaptive response in multiple tissues and is highly expressed in the developing central nervous system. A former study reported that NFAT5 activation through hypertonic stress increases the expression of the dopa decarboxylase enzyme (DDC), also known as aromatic-l-amino-acid decarboxylase (AADC), in human renal proximal tubule cells, leading to an increase of dopamine synthesis. In a previous study, we identified NFAT5 as a candidate gene for cocaine dependence, a complex psychiatric disorder in which dopaminergic neurotransmission plays an important role. Therefore, to test the hypothesis that NFAT5 may also affect dopamine levels in the nervous system through the regulation of DDC expression, we examined this regulation using two neural dopaminergic cell lines, SH-SY5Y and PC12. The effect of NFAT5 on the expression of the neuronal isoform of DDC was evaluated by qRT-PCR. Upon hypertonic stress, NFAT5 was activated and accumulated into the nuclei and, subsequently, the expression of NFAT5 and its known targets sodium/myo-inositol cotransporter 1 (SMIT) and sodium chloride/taurine cotransporter (TAUT) increased, as expected. However, the expression of DDC decreased. When silencing the expression of NFAT5 with a specific shRNA we observed that the downregulation of DDC is independent from NFAT5 in both cell lines and is due to hypertonic stress. In conclusion, NFAT5 does not regulate the expression of the neuronal isoform of DDC in neural dopaminergic cell lines and, consequently, it does not modulate dopamine synthesis through DDC.
- Published
- 2020
247. Forearm rotation modifies the scapholunate joint muscle control. A kinetic study in cadavers
- Author
-
Esplugas, M, Salva-Coll, G, Garcia-Elias, M, Lluch-Bergada, A, Puig De La Bellacasa, I, Fernandez, N, Llusá-Pérez, M, Esplugas, M, Salva-Coll, G, Garcia-Elias, M, Lluch-Bergada, A, Puig De La Bellacasa, I, Fernandez, N, and Llusá-Pérez, M
- Published
- 2020
248. Forearm supination must be avoided during scapholunate ligament-stability exercise programme. A kinetic study in cadavers
- Author
-
Esplugas, M, Lluch-Bergadà, A, Garcia-Elias, M, Salvà-Coll, G, Fernandez, N, Esplugas, M, Lluch-Bergadà, A, Garcia-Elias, M, Salvà-Coll, G, and Fernandez, N
- Published
- 2020
249. Novel Pulmonary Vasculitis with Splendore–Hoeppli Reaction in Grey Seals (Halichoerus grypus) Associated with Otostrongylus circumlitus Infection
- Author
-
Barnett, J.E.F., Bexton, S., Fraija-Fernández, N., Chooneea, D., and Wessels, M.E.
- Published
- 2019
- Full Text
- View/download PDF
250. The Influence of Ficus deltoidea in Preserving Alveolar Bone in Ovariectomized Rats
- Author
-
Omar, N. I., primary, Baharin, B., additional, Lau, S. F., additional, Ibrahim, N., additional, Mohd, N., additional, Ahmad Fauzi, A., additional, Muhammad, N., additional, and Fernandez, N. M., additional
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.